C07D

Heterocyclic Compounds (Drug Molecules)

EPO Patent Bulletin

← All categories
Filter: All Correction Grant Limitation Publication Search Report

740 items

Grant

Process For The Recovery Of Epsilon Caprolactam From Polyamide 6 Comprising Fishing Nets

EP4469433B1 · Mar 18, 2026
Grant

Tetrahydropyranopyrazole Derivatives For The Treatment Of Cancer And Viral Infections

EP4469461B1 · Mar 18, 2026
Grant

Molecular Sensors, Method And Kit For The Detection And Quantification Of Carbon Dioxide

EP4465883B1 · Mar 18, 2026
Grant

Deuterated Or Partially Deuterated N,N Dimethyltryptamine Compounds

EP4275753B1 · Mar 18, 2026
Grant

Non Aqueous Electrolyte Solution For Lithium Secondary Battery And Lithium Secondary Battery Including The Same

EP4258408B1 · Mar 18, 2026
Grant

Pyrrolo[2,1 F][1,2,4]Triazines Derivatives As Inhibitors Of Dyrk1 A

EP4415816B1 · Mar 18, 2026
Grant

Method For Producing Carbonyl Halide

EP4292708B1 · Mar 18, 2026
Grant

Fragrance Substances And Formulation Containing Them

EP4433483B1 · Mar 18, 2026
Grant

Urea Derivatives Which Can Be Used To Treat Cancer

EP4334298B1 · Mar 18, 2026
Grant

Triazine Derivatives For The Treatment Of Tumours And Neurodegenerative Disorders

EP4359391B1 · Mar 18, 2026
Grant

Positive Electrode Active Material, Positive Electrode And Lithium Secondary Battery Including The Same

EP4199179B1 · Mar 18, 2026
Grant

Nlrp3 Inhibitors

EP4337652B1 · Mar 18, 2026
Grant

Antiviral Prodrugs And Nanoformulations Thereof

EP4234561B1 · Mar 18, 2026
Grant

Small Molecule Urea Derivatives As Sting Antagonists

EP4384268B1 · Mar 18, 2026
Grant

3 Hydroxyadipic Acid 3,6 Lactone Composition

EP4306515B1 · Mar 18, 2026
Correction

N Alkyl O Aryl Carbamates Of 6 H Dibenzo[]B,D]Pyran 3,8 Diols As Mitophagy Enhancers

EP4330245B8 · Mar 18, 2026
Grant

N Alkyl O Aryl Carbamates Of 6 H Dibenzo[]B,D]Pyran 3,8 Diols As Mitophagy Enhancers

EP4330245B1 · Mar 18, 2026
Correction

Substituted Quinoline Analogs As Aldehyde Dehydrogenase 1 A1 (Aldh1 A1) Inhibitors

EP4155300B8 · Mar 18, 2026
Grant

New Contrast Agent For Use In Magnetic Resonance Imaging

EP4308551B1 · Mar 18, 2026
Limitation

Method For Preparing An Enantiomerically Enriched Form Of 3 (2 Chlorothiazol 5 Yl) 8 Methyl 7 Oxo 6 Phenyl 2,3 Dihydrothiazolo[3,2 A]Pyrimidin 4 Ium 5 Olate

EP4281462C0 · Mar 18, 2026
Grant

Method For Preparing An Enantiomerically Enriched Form Of 3 (2 Chlorothiazol 5 Yl) 8 Methyl 7 Oxo 6 Phenyl 2,3 Dihydrothiazolo[3,2 A]Pyrimidin 4 Ium 5 Olate

EP4281462B1 · Mar 18, 2026
Limitation

Method For Preparing An Enantiomerically Enriched Form Of 3 (2 Chlorothiazol 5 Yl) 8 Methyl 7 Oxo 6 Phenyl 2,3 Dihydrothiazolo[3,2 A]Pyrimidin 4 Ium 5 Olate

EP4281461C0 · Mar 18, 2026
Grant

Method For Preparing An Enantiomerically Enriched Form Of 3 (2 Chlorothiazol 5 Yl) 8 Methyl 7 Oxo 6 Phenyl 2,3 Dihydrothiazolo[3,2 A]Pyrimidin 4 Ium 5 Olate

EP4281461B1 · Mar 18, 2026
Limitation

Pyridazine Compounds For Inhibiting Nlrp3

EP4320102C0 · Mar 18, 2026
Grant

Pyridazine Compounds For Inhibiting Nlrp3

EP4320102B1 · Mar 18, 2026
Grant

Khk Inhibitors

EP4313967B1 · Mar 18, 2026
Grant

Quinoxaline Derivatives And Uses Thereof

EP4288426B1 · Mar 18, 2026
Grant

Heteroaromatic Spermidine Analogues And Their Anticancer Activity

EP4288422B1 · Mar 18, 2026
Grant

Methods Of Iron Catalyzed C H Bond Amination

EP4140974B1 · Mar 18, 2026
Grant

Materials For Electronic Devices

EP4037000B1 · Mar 18, 2026
Limitation

N [4 (6 Fluoro 3,4 Dihydro 2(1 H) Isoquinolinyl) 2,6 Dimethylphenyl] 1 Methyl Cyclopropane Acetamide, A Potassium Channel Regulator For The Treatment Of Epilepsy

EP4074696C0 · Mar 18, 2026
Grant

N [4 (6 Fluoro 3,4 Dihydro 2(1 H) Isoquinolinyl) 2,6 Dimethylphenyl] 1 Methyl Cyclopropane Acetamide, A Potassium Channel Regulator For The Treatment Of Epilepsy

EP4074696B1 · Mar 18, 2026
Grant

Compounds For Prevention Or Treatment Of Neurodegenerative Disorders

EP4200299B1 · Mar 18, 2026
Grant

Aniline Compound Used As Rory Regulator

EP4151626B1 · Mar 18, 2026
Grant

Immunomodulator

EP4177249B1 · Mar 18, 2026
Grant

Modulators Of G Protein Coupled Receptor 88

EP4263492B1 · Mar 18, 2026
Grant

Organic Electroluminescent Element

EP4174062B1 · Mar 18, 2026
Grant

Compounds And Compositions As Sppl2 A Inhibitors

EP4214210B1 · Mar 18, 2026
Grant

Substituted Pyridazinone Herbicides

EP4267556B1 · Mar 18, 2026
Grant

Process For The Synthesis Of Cannabidiol And Intermediates Thereof

EP3923917B1 · Mar 18, 2026
Grant

Organic Compound Of Formula (I) For Use In Organic Electronic Devices, An Organic Electronic Device Comprising A Compound Of Formula (I) And A Display Device Comprising The Organic Electronic Device

EP4169086B1 · Mar 18, 2026
Grant

Preparation Of Substituted 4 (N' Hydroxycarbamimidoyl)benzoic Acids

EP4157824B1 · Mar 18, 2026
Grant

Compounds Useful For Inhibiting Ret Kinase

EP4143184B1 · Mar 18, 2026
Grant

Modulators Of Complex I

EP4291552B1 · Mar 18, 2026
Grant

2 Aminoquinazolinone Derivatives As Methionine Adenosyltransferase 2 A Inhibitors

EP4165040B1 · Mar 18, 2026
Grant

Brm Targeting Compounds And Associated Methods Of Use

EP4161935B1 · Mar 18, 2026
Grant

Method For Obtaining Biosourced Polyepoxides With Improved Properties

EP4172161B1 · Mar 18, 2026
Grant

Crystalline Form Of Jak Inhibitor And Application Thereof

EP4108664B1 · Mar 18, 2026
Grant

Isoquiniline Nrf2 Agonists

EP4139295B1 · Mar 18, 2026
Grant

Isoquiniline Nrf2 Agonists

EP4139294B1 · Mar 18, 2026
Grant

Process For Preparing A Cot Inhibitor Compound

EP4126862B1 · Mar 18, 2026
Correction

Difluoromethyl Pyridin 2 Yl Triazoles

EP4192823B9 · Mar 18, 2026
Grant

Alkyl Amine Harmine Derivatives For Promoting Bone Growth

EP3915987B1 · Mar 18, 2026
Grant

A Nebulizer Comprising A Pharmaceutical Composition Comprising 2' Substituted Carba Nucleoside Analogs For Antiviral Treatment

EP3932931B1 · Mar 18, 2026
Grant

Dihydro 2 Pyrrolo[3,4 C]Pyridine Derivatives As Gabaa A5 Receptor Modulators

EP4126858B1 · Mar 18, 2026
Grant

Substituted Vinyl Piperazine Piperidine Urea Derivatives As Anticancer Agents

EP4163273B1 · Mar 18, 2026
Grant

Novel Adamantane Derivatives As Inhibitors Of Focal Adhesion Kinase

EP4074697B1 · Mar 18, 2026
Grant

Cd4 Mimic Compound With Anti Hiv Activity

EP4052726B1 · Mar 18, 2026
Grant

Heterocyclic Compound And Organic Light Emitting Device Comprising Same

EP4050001B1 · Mar 18, 2026
Grant

Long Acting Low Addiction Hnk Derivative And Preparation Method Therefor

EP4148048B1 · Mar 18, 2026
Grant

Pharmaceutical Composition Containing Nitroxoline, Nitroxoline Tablet, Preparation Method Therefor And Use Thereof

EP4085902B1 · Mar 18, 2026
Grant

Process For Producing Functionalized Polythiophenes

EP4151640B1 · Mar 18, 2026
Grant

Heterocyclic Compound

EP4046688B1 · Mar 18, 2026
Grant

Organic Thin Film, Method For Producing Organic Thin Film, Organic Electroluminescent Element, Display Device, Lighting Device, Organic Thin Film Solar Cell, Thin Film Transistor, Photoelectric Conversion Element, Coating Composition And Material For Organic Electroluminescent Elements

EP4026836B1 · Mar 18, 2026
Grant

Imidazopyridine Derivative And Pharmaceutical Composition Comprising Same As Active Ingredient

EP4023647B1 · Mar 18, 2026
Grant

Crystalline Form Of Dimethylamino Micheliolide Fumarate Monohydrate

EP4071143B1 · Mar 18, 2026
Grant

Antimalarial Agents

EP4061375B1 · Mar 18, 2026
Grant

Preparation Of Trifarotene And Intermediates And Polymorphs Thereof

EP4073035B1 · Mar 18, 2026
Grant

Synthesis Of Amanin And Its Derivatives

EP4077353B1 · Mar 18, 2026
Grant

Heterocyclic Compound, Organic Light Emitting Diode Comprising Same, Composition For Organic Layer Of Organic Light Emitting Diode, And Method For Manufacturing Organic Light Emitting Diode

EP4043454B1 · Mar 18, 2026
Grant

Iso Citrate Dehydrogenase (Idh) Inhibitor

EP4041732B1 · Mar 18, 2026
Grant

Drug Combinations Of Entecavir And A Tlr7 Agonist For Use In The Treatment Of Hbv

EP4029503B1 · Mar 18, 2026
Grant

Crystalline Forms Of A Capsid Protein Assembly Inhibitor Containing A Pyrrole Ring, And Application Thereof

EP4036078B1 · Mar 18, 2026
Grant

Pyridopyrimidine Derivatives Useful As Kras G12 C And Kras G12 D Inhibitors In The Treatment Of Cancer

EP4048671B1 · Mar 18, 2026
Grant

Non Lysosomal Glucosylceramidase Inhibitors And Uses Thereof

EP3966199B1 · Mar 18, 2026
Grant

Gem Disubstituted Heterocyclic Compounds And Their Use As Idh Inhibitors

EP4055015B1 · Mar 18, 2026
Grant

Bicyclic Nitrogen Containing Heterocycles As Inhibitors Of Salt Induced Kinase Sik2

EP4051677B1 · Mar 18, 2026
Grant

Prodrugs Of Monomethyl Fumarate

EP3956287B1 · Mar 18, 2026
Grant

Cell Activator Of Animal Cell

EP3960244B1 · Mar 18, 2026
Limitation

Phenazine Derivative And Use Thereof For The Treatment Of Cancer

EP4007639C0 · Mar 18, 2026
Grant

Phenazine Derivative And Use Thereof For The Treatment Of Cancer

EP4007639B1 · Mar 18, 2026
Grant

Pyrrolopyrazole Derivative

EP3936192B1 · Mar 18, 2026
Grant

Compounds For Electronic Devices

EP4078692B1 · Mar 18, 2026
Grant

2 Phenoxy Pyrimidine Derivatives As Herbicidal Compounds

EP4010323B1 · Mar 18, 2026
Grant

Isoquinoline Derivatives And Their Use For The Treatment Of Parasitic Infections

EP4003524B1 · Mar 18, 2026
Grant

Phosphatidylinositol 3 Kinase Inhibitors

EP3952870B1 · Mar 18, 2026
Grant

Preparation Method For Amide Compounds And Use Thereof In Medical Field

EP3950682B1 · Mar 18, 2026
Grant

Synthesis Of Coelenterazine

EP3966214B1 · Mar 18, 2026
Grant

4 [[2 [[5 [1 (1 H Indol 2 Yl) 2 (Phenyl) 1 Ethen 1 Yl] 2 Pyridinyl]Oxy]Ethyl]Amino] 2 Butenamide Derivatives For The Treatment Of Estrogen Receptor Positive Breast Cancer

EP3889133B1 · Mar 18, 2026
Grant

Integrated Methods And Systems For Producing Amide And Nitrile Compounds

EP3935041B1 · Mar 18, 2026
Grant

Pyrazine Derivative As Chk1 Inhibitor

EP3811944B1 · Mar 18, 2026
Grant

Tetrahydro Pyrido[3,4 B]Indole Estrogen Receptor Modulators And Uses Thereof

EP3760623B1 · Mar 18, 2026
Grant

Preparation Of 2 Substituted 4 Methyl Tetrahydropyrans Of 2 Substituted 4 Hydroxy 4 Methyl Tetrahydropyrans As Starting Materials

EP3873888B1 · Mar 18, 2026
Grant

Dihydropyran Derivatives And Use Thereof As Fragrance

EP3867338B1 · Mar 18, 2026
Grant

Antagonists Of Human Integrin (Alpha4)(Beta7)

EP3773573B1 · Mar 18, 2026
Grant

Compounds And Uses Thereof

EP3768269B1 · Mar 18, 2026
Grant

Receptor Inhibitor, Pharmaceutical Composition Comprising Same, And Use Thereof

EP3770148B1 · Mar 18, 2026
Grant

Deuterated Compounds As Rock Inhibitors

EP3768661B1 · Mar 18, 2026
Grant

Organic Compounds

EP3768254B1 · Mar 18, 2026
Grant

Antibacterial Agents: O Alkyl Deuterated Pyronins

EP3752143B1 · Mar 18, 2026
Correction

Thrb Receptor Agonist Compound And Preparation Method And Use Thereof

EP3893889B8 · Mar 18, 2026
Grant

Cyanoaryl Aniline Compounds For Treatment Of Dermal Disorders

EP3883552B1 · Mar 18, 2026
Grant

Novel Compounds For The Treatment Of Respiratory Diseases

EP3877382B1 · Mar 18, 2026
Grant

Solvent Free Cross Coupling Reaction, And Production Method Using Said Reaction

EP3872055B1 · Mar 18, 2026
Grant

Substituted Heterocycle Fused Gamma Carbolines Synthesis

EP3609891B1 · Mar 18, 2026
Grant

Oxazole And Oxadiazole Derivatives Useful As Agonists Of Free Fatty Acid Receptor 1

EP3956323B1 · Mar 18, 2026
Grant

Factor Xiia Inhibitors

EP3788039B1 · Mar 18, 2026
Grant

Bioispired Proteasome Activators With Antiageing Activity

EP3761950B1 · Mar 18, 2026
Grant

2 Cyanopyrimidin 4 Yl Carbamate Or Urea Derivative Or Salt Thereof, And Pharmaceutical Composition Including Same

EP3778576B1 · Mar 18, 2026
Grant

Synthesis Of Coelenterazine

EP3830088B1 · Mar 18, 2026
Grant

Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Diseases

EP3806853B1 · Mar 18, 2026
Grant

Method For Producing Dihydroxyindoles

EP3689852B1 · Mar 18, 2026
Grant

Anti Inflammatory, Anti Cancer, And Anti Angiogenic Compounds, Pharmaceutical Compositions, And Methods Of Making And Using Thereof

EP3687972B1 · Mar 18, 2026
Grant

Crystal Form And Salt Of 3 (3,5 Dichloro 4 Hydroxybenzoyl) 1,1 Dioxo 2,3 Dihydro 1,3 Benzothiazole

EP3617199B1 · Mar 18, 2026
Grant

15 Idene 14 Deoxy 11,12 Dehydroandrographolide Derivative And Application Thereof In Preparing Anti Fibrosis Drugs

EP3608313B1 · Mar 18, 2026
Grant

Edaravone For Treating Amyotrophic Lateral Sclerosis Or Preventing Progression Of Phase Of Amyotrophic Lateral Sclerosis

EP3520788B1 · Mar 18, 2026
Grant

Novel Modulators Of The Sigma 2 Receptor And Their Method Of Use

EP3600290B1 · Mar 18, 2026
Grant

Continuous Dilution Of Polyisocyanates

EP3649113B1 · Mar 18, 2026
Grant

Anticancer Compounds

EP3612172B1 · Mar 18, 2026
Limitation

Isoxazole N Linked Carbamoyl Cyclohexyl Acids As Lpa Antagonists

EP3728210C0 · Mar 18, 2026
Grant

Isoxazole N Linked Carbamoyl Cyclohexyl Acids As Lpa Antagonists

EP3728210B1 · Mar 18, 2026
Grant

Compound, Coating Composition Comprising Same, And Organic Light Emitting Element Comprising Same

EP3578553B1 · Mar 18, 2026
Grant

Deuterated Derivatives Of Ruxolitinib

EP3450434B1 · Mar 18, 2026
Grant

Aryl And Heteroaryl Ether Derivatives As Liver X Receptor Beta Agonists

EP3526196B1 · Mar 18, 2026
Grant

Chemical Compounds As Antibiotics

EP3601224B1 · Mar 18, 2026
Grant

Processes For Preparing Acc Inhibitors And Solid Forms Thereof

EP3589636B1 · Mar 18, 2026
Grant

Substituted Pyrazolopyrimidinone Compounds As Pde2 Inhibitors

EP3562828B1 · Mar 18, 2026
Grant

Particulate Nucleating Agent And Method For Manufacturing Thereof

EP3362509B1 · Mar 18, 2026
Grant

Ion Channel Inhibitory Compounds, Pharmaceutical Formulations And Uses

EP3340988B1 · Mar 18, 2026
Grant

Piperazinyl Norbenzomorphan Compounds And Methods For Using The Same

EP3364976B1 · Mar 18, 2026
Grant

Processable Polymers And Methods Of Making And Using Thereof

EP3322710B1 · Mar 18, 2026
Grant

Estrogen Receptor Modulators

EP3442971B1 · Mar 18, 2026
Grant

Vortioxetine Pamoic Acid Salt And Crystal Form Thereof

EP3438099B1 · Mar 18, 2026
Grant

Solid Forms Of A Thienopyrimidinedione Acc Inhibitor And Methods For Production Thereof

EP3423456B1 · Mar 18, 2026
Grant

Adenine Derivatives As Protein Kinase Inhibitors

EP3452477B1 · Mar 18, 2026
Grant

Folate Receptor Binding Conjugates Of Antifolates

EP2349274B1 · Mar 18, 2026
Grant

Composition And Organic Optoelectric Device And Display Device

EP2821459B1 · Mar 18, 2026
Publication

Compositions Of Mu Opioid Receptor Modulators And Methods Of Use Thereof

EP2026030728A1 · Mar 18, 2026
Publication

Substituted Imidazolyl Dihydropyrimidine 2,4 Dione And Substituted Imidazolyl Piperidine 2,6 Dione Derivatives And Uses Thereof

EP2026030722A1 · Mar 18, 2026
Publication

Prodrugs Of Alkylthio Dadme Immucillin A Compounds And Their Use As Anticancer Therapeutic Agents

EP2026029682A1 · Mar 18, 2026
Publication

4 Cyclopropyl Pyrrole Derivative And Use Thereof

EP2026029625A1 · Mar 18, 2026
Publication

Microcrystalline Polymorphs Of Lmp744 And Uses Thereof

EP2026029972A1 · Mar 18, 2026
Publication

Microcrystalline Polymorphs Of Lmp400 And Uses Thereof

EP2026029971A1 · Mar 18, 2026
Publication

Method To Synthesise Cyclic Compounds Containing Urethane Or Urea Groups

EP2026030176A1 · Mar 18, 2026
Publication

Nitrogen Containing Heterocyclic Compound And Method For Controlling Plant Diseases

EP2026029173A1 · Mar 18, 2026
Publication

Azaindazole Macrocycle Solid Forms

EP2026030285A1 · Mar 18, 2026
Publication

Method For Promoting Formic Acid Synthesis Reaction, And Ionic Liquid

EP2026029047A1 · Mar 18, 2026
Publication

Urea Or Carbamate Lipid Having Cyclic Group In Side Chain, Lipid Nanoparticles Thereof, And Pharmaceutical Composition Thereof

EP2026029046A1 · Mar 18, 2026
Publication

Pyrazolopyrimidine Compound And Pharmaceutical Use Thereof

EP2026029041A1 · Mar 18, 2026
Publication

Radiation Sensitive Composition, Resist Pattern Formation Method, And Compound

EP2026029200A1 · Mar 18, 2026
Publication

Radioactive Triphenylpyrazole Compound

EP2026029180A1 · Mar 18, 2026
Publication

Glucagon Like Peptide 1 (Glp1) Receptor Ligands For The Delivery Of Therapeutic Agents To Cardiomyocytes

EP2026030212A1 · Mar 18, 2026
Publication

Cardiomyocyte Delivery Platforms And Methods Of Use

EP2026030210A1 · Mar 18, 2026
Publication

A Hypoxia Responsive Ionizable Lipid

EP2026030374A1 · Mar 18, 2026
Publication

Organic Metal Halide Hybrid Scintillators And Methods Of Making

EP2026030550A1 · Mar 18, 2026
Publication

Inhibition Of Glial Cell Activation

EP2026030500A1 · Mar 18, 2026
Publication

Treatment Of Conditions Related To Cxcr2 Loss Of Function

EP2026030589A1 · Mar 18, 2026
Publication

Resist Composition, Method For Forming Resist Pattern, Compound, And Acid Diffusion Control Agent

EP2026028814A1 · Mar 18, 2026
Publication

Method For Estimation Of Compounds In A Mixture

EP2026028222A1 · Mar 18, 2026
Publication

Subunit Selective N Methyl D Aspartate Receptors Modulators And Uses Related Thereto

EP2026030391A1 · Mar 18, 2026
Publication

Light Conversion Film Based On Benzotriazole Compound, Preparation Method Therefor, And Use Thereof

EP2026026954A1 · Mar 18, 2026
Publication

Preparation Method For Nitrogen Containing Heterocyclic Derivative, And Intermediate Of Nitrogen Containing Heterocyclic Derivative

EP2026026942A1 · Mar 18, 2026
Publication

Egfr Degrader And Preparation Method Therefor And Use Thereof

EP2026026940A1 · Mar 18, 2026
Publication

The Crystalline Forms Of A Compound

EP2026026904A1 · Mar 18, 2026
Publication

Ultra Short Acting Neuromuscular Blocking Agent, Preparation Method Therefor, And Use Thereof

EP2026026886A1 · Mar 18, 2026
Publication

Compound For Selectively Degrading Smarca2/4 And Use Thereof

EP2026026885A1 · Mar 18, 2026
Publication

Heterocyclic Derivative Inhibitor, And Preparation Thereof And Use Thereof

EP2026026878A1 · Mar 18, 2026
Publication

Negative Photosensitive Resin Composition, Cured Film Using Same, Cured Relief Pattern Production Method, And Semiconductor Device

EP2026029152A1 · Mar 18, 2026
Publication

Cyclic Lactone Compound And Medical Use Thereof

EP2026026870A1 · Mar 18, 2026
Publication

Ionizable Lipids And Use Thereof

EP2026026869A1 · Mar 18, 2026
Publication

Macrocyclic Compound As Tyk2 Inhibitor And Pharmaceutical Composition Thereof

EP2026026866A1 · Mar 18, 2026
Publication

Pyridyl Substituted Imidazole Ring Compound And Preparation Method Therefor, Insecticidal Composition, And Use

EP2026026591A1 · Mar 18, 2026
Publication

Tricyclic Compounds And Uses Thereof

EP2026026840A1 · Mar 18, 2026
Publication

Carbocyclic Or Heterocyclic Derivative, Preparation Method Therefor And Use Thereof

EP2026026828A1 · Mar 18, 2026
Publication

Crbn Binding Compounds And Uses Thereof

EP2026026826A1 · Mar 18, 2026
Publication

Macrocyclic Alk Inhibitor, Preparation Method Therefor And Use Thereof

EP2026026817A1 · Mar 18, 2026
Publication

Solid Oral Composition Of Telmisartan Sodium And Preparation Thereof

EP2026028111A1 · Mar 18, 2026
Publication

Organometallic Complex And Light Emitting Device

EP2026028064A1 · Mar 18, 2026
Publication

Compound, Hole Transport Material, Hole Transport Material For Perovskite Solar Cell, Perovskite Solar Cell, Structure, And Method For Producing Perovskite Solar Cell

EP2026028694A1 · Mar 18, 2026
Publication

Resist Composition, Resist Pattern Formation Method, Compound, And Polymer Compound

EP2026028725A1 · Mar 18, 2026
Publication

Oxocarbon Based Compound

EP2026028723A1 · Mar 18, 2026
Publication

Imidazole Fused Ring Compound, And Preparation Method Therefor And Use Thereof

EP2026026971A1 · Mar 18, 2026
Publication

Fused Ring Compound, And Intermediate Thereof And Use Thereof

EP2026026970A1 · Mar 18, 2026
Publication

Compound Serving As Cgas Inhibitor

EP2026026969A1 · Mar 18, 2026
Publication

Compound Containing Aromatic Fused Ring, Pharmaceutical Composition Thereof And Use Thereof

EP2026026968A1 · Mar 18, 2026
Publication

Acryloyl Compound And Use Thereof

EP2026026967A1 · Mar 18, 2026
Publication

Tacc Inhibitor Compound, Pharmaceutical Composition, And Preparation Method Therefor And Use Thereof

EP2026026956A1 · Mar 18, 2026
Publication

Compound As Parp1 Inhibitor And Pharmaceutical Composition Comprising The Same

EP2026028140A1 · Mar 18, 2026
Publication

Antibody Drug Conjugates With Dual Pi3 K/Mtor Inhibitors And Uses Thereof

EP2026030331A1 · Mar 18, 2026
Publication

Actinic Ray Sensitive Or Radiation Sensitive Resin Composition, Resist Film, Pattern Forming Method, And Method For Producing Electronic Device

EP2026028674A1 · Mar 18, 2026
Publication

Liquid Crystal Compound, Preparation Method Therefor And Use Thereof

EP2026026860A1 · Mar 18, 2026
Publication

Novel Nlrp3 Inflammasome Inhibitors

EP2026026674A1 · Mar 18, 2026
Publication

Heterocyclic Substituted Sulfonamide Compound, Pharmaceutical Composition Comprising Same, And Use

EP2026026768A1 · Mar 18, 2026
Publication

Heterocyclic Compound, And Preparation Method Therefor And Use Thereof

EP2026026755A1 · Mar 18, 2026
Publication

Anthracycline Derivative, And Preparation Method Therefor And Use Thereof

EP2026026748A1 · Mar 18, 2026
Publication

Crystal Form Of Pyridopyrazole Derivative And Preparation Method Therefor And Use Thereof

EP2026026740A1 · Mar 18, 2026
Publication

Sulfonamide Compound And Pharmaceutical Use Thereof

EP2026026739A1 · Mar 18, 2026
Publication

Oxazolo Or Thiazolo Indole Compound Or Derivative Thereof, And Use Thereof

EP2026026716A1 · Mar 18, 2026
Publication

Triazole Containing Trifluoromethyl Oxadiazole Derivative And Use Thereof, And Drug For Controlling And Eliminating Phytopathogenic Fungi

EP2026026785A1 · Mar 18, 2026
Publication

Novel Substituted Heterocyclic Compound Serving As Vav1 Protein Target Degradation Agent

EP2026026773A1 · Mar 18, 2026
Publication

Fumarate Crystal Form Of Oxaspirocyclic Derivative, And Preparation Method Therefor And Use Thereof

EP2026026772A1 · Mar 18, 2026
Publication

Crystal Form Of Fluoro Substituted Isoindoline Compound, Preparation Method Therefor And Use Thereof

EP2026026769A1 · Mar 18, 2026
Publication

2 Indolone Compound, Ligand Drug Conjugate Thereof, Preparation Method Therefor, And Use Thereof

EP2026026857A1 · Mar 18, 2026
Publication

Pyrazolopyridine Compound And Use Thereof

EP2026026350A1 · Mar 18, 2026
Publication

Fap Targeting Compound And Preparation Method Therefor

EP2026025908A1 · Mar 18, 2026
Publication

Pyridyl Substituted Heterocyclic Compound And Preparation Method Therefor, Insecticidal Composition And Use

EP2026026182A1 · Mar 18, 2026
Publication

Synthesis Method For Converting Pyridine Into Aromatic Dialdehyde

EP2026026000A1 · Mar 18, 2026
Publication

6,7 Dihydro 5 H Pyrrolo[1,2 A]Imidazole Derivative, Preparation Method Therefor, And Use Thereof

EP2026025999A1 · Mar 18, 2026
Publication

Compounds For Inhibition Of Thyroid Stimulating Hormone Receptor

EP2026030578A1 · Mar 18, 2026
Publication

Process For Making Seladelpar

EP2026030479A1 · Mar 18, 2026
Publication

Wee1 Degrading Compounds And Uses Thereof

EP2026030657A1 · Mar 18, 2026
Publication

Gip Receptor Agonist Compounds

EP2026030603A1 · Mar 18, 2026
Publication

Method For Preparing Chiral Intermediate Of Niraparib By Means Of Chemical Enzymatic Method

EP2026026030A1 · Mar 18, 2026
Publication

Fungicidal Substituted Azoles

EP2026030052A1 · Mar 18, 2026
Publication

Nitazene Analogs And Conjugates And Methods Of Production And Use Thereof

EP2026030017A1 · Mar 18, 2026
Publication

[1,2,4]Triazolo[1,5 A]Pyrimidin 7(4 H) One Derivatives Useful As Inhibitors Of Wrn

EP2026028180A1 · Mar 18, 2026
Publication

Compounds Useful As Inhibitors Of Werner Syndrome Recq Helicase (Wrn)

EP2026028179A1 · Mar 18, 2026
Publication

Method, Composition And Kit For Psychoactive Substances Detection

EP2026028146A1 · Mar 18, 2026
Publication

Process For The Preparation Of Tovorafenib

EP2026028053A2 · Mar 18, 2026
Publication

Compounds Useful For The Treatment Of Disorders And Methods Related Thereto

EP2026030444A1 · Mar 18, 2026
Publication

Systems And Methods For The Production Of Levulinic Acid, Furfural, And Formic Acid

EP2026030122A1 · Mar 18, 2026
Publication

Solid Forms Of Ras Inhibitor

EP2026027450A1 · Mar 18, 2026
Publication

N Cyanopyrrolidine Deviratives Having Activity As Inhibiotrs Of Ubiquitin Specific Peptidase 30

EP2026027857A1 · Mar 18, 2026
Publication

Thiomethyl Carbonyl Compounds And Use Thereof As Hdac6 Inhibitors

EP2026027696A1 · Mar 18, 2026
Publication

Synthesis Of Afoxolaner, Fluralaner And Lotilaner

EP2026027745A1 · Mar 18, 2026
Publication

Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Diseases Such As Cancer

EP2026027726A1 · Mar 18, 2026
Publication

Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Diseases Such As Cancer

EP2026027643A1 · Mar 18, 2026
Publication

Compounds And Pharmaceutical Compositions Thereof For The Treatment Of Diseases Such As Cancer

EP2026027635A1 · Mar 18, 2026
Publication

Sequencing Reagents Using Guanidinylating Agents

EP2026030423A1 · Mar 18, 2026
Publication

Compounds As Sort1 Inhibitors

EP2026029204A1 · Mar 18, 2026
Publication

Synthesis Of 5 (1 Cyanocyclopropyl) 3 Ethylsulfanyl Pyridine 2 Carbonitrile

EP2026027562A1 · Mar 18, 2026
Publication

Crystalline Naloxone Dimethylformamide Solvate, Methods For Its Preparation And Its Use As A Reagent In A Method Of Making Naloxone

EP2026027618A1 · Mar 18, 2026
Publication

Synthesis Of Organic Macrocycles Through Clip Off Chemistry

EP2026027604A1 · Mar 18, 2026
Publication

Synthesis Of An Intermediate Of A Gadolinium Based Contrast Agent

EP2026027591A1 · Mar 18, 2026
Publication

Process For Decolorization Of Light Stabilizers

EP2026027355A1 · Mar 18, 2026
Publication

Cyclophilin Modulators

EP2026027787A1 · Mar 18, 2026
Publication

Fused Pentacyclic Imidazole Derivatives

EP2026027449A1 · Mar 18, 2026
Publication

Blended Catalyst Mix For Epoxidation

EP2026027443A1 · Mar 18, 2026
Publication

4 Oxo 1,4 Dihydropyridazine Derivatives As Aryl Hydrocarbon Receptor Agonists For The Treatment Of Cancer

EP2026027421A1 · Mar 18, 2026
Publication

Herbicidal Compounds

EP2026027368A1 · Mar 18, 2026
Publication

Hydroxy Dihydropyridinone Carboxamides As Pesticides

EP2026027375A1 · Mar 18, 2026
Search Report

Improved Synthesis Of Kras G12 C Inhibitor Compound

EP4700030A3 · AMGEN, INC. · Mar 18, 2026
Publication

Improved Synthesis Of Kras G12 C Inhibitor Compound

EP4700030A2 · AMGEN, INC. · Mar 18, 2026
Publication

A Process For Preparing 4 Methyl 2 Propan 2 Yl Pyridine 3 Carbonitrile

EP4711357A2 · AMGEN, INC. · Mar 18, 2026
Publication

Pharmaceutical Agent For Treating Amyotrophic Lateral Sclerosis Or Suppressing Disease Progress Thereof

EP4700016A2 · Tanabe Pharma Corporation · Mar 18, 2026
Search Report

Solid State Forms Of Asciminib And Processes For The Preparation Thereof

EP4691464A3 · TAPI Czech Industries s.r.o. · Mar 18, 2026
Publication

Solid State Forms Of Asciminib And Processes For The Preparation Thereof

EP4691464A2 · TAPI Czech Industries s.r.o. · Mar 18, 2026
Publication

Prostaglandin Ep4 Receptor Antagonist Compounds

EP4692085A2 · Nxera Pharma UK Limited · Mar 18, 2026
Publication

Onium Salt, Chemically Amplified Positive Resist Composition And Resist Pattern Forming Process

EP4703795A2 · Shin-Etsu Chemical Co., Ltd. · Mar 18, 2026
Publication

Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases

EP4682148A2 · AbbVie Ireland Unlimited Company · Mar 18, 2026
Publication

Salts And Prodrugs Of 1 Methyl D Tryptophan

EP4659747A2 · Lumos Pharma, Inc. · Mar 18, 2026
Publication

Anti C Met Antibody Drug Conjugates

EP4656248A2 · AbbVie Manufacturing Management Unlimited Company · Mar 18, 2026
Publication

Protein Degraders And Uses Thereof

EP4624467A2 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Method Of Synthesizing Thyroid Hormone Analogs And Polymorphs Thereof

EP4691557A2 · Madrigal Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4620470A2 · Kymera Therapeutics, Inc. · Mar 18, 2026
Search Report

Irak Degraders And Uses Thereof

EP4613773A3 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4613773A2 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Heteroalkyl Dihydroquinoline Sulfonamide Compounds

EP4595965A2 · Amgen Inc. · Mar 18, 2026
Publication

Methods For Array Synthesis

EP4556467A2 · Vibrant Holdings, LLC · Mar 18, 2026
Publication

Somatostatin Modulators And Uses Thereof

EP4548974A2 · Crinetics Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Bcl 2 Inhibitors

EP4545515A1 · BeOne Medicines I GmbH · Mar 18, 2026
Publication

Improved Process For Preparation Of Apalutamide

EP4541786A2 · Synthon B.V. · Mar 18, 2026
Publication

New Integrated Tumor Diagnosis And Treatment Agent Targeting Prostate Specific Membrane Antigen

EP2026025641A1 · Mar 18, 2026
Publication

Method For Producing Fluorinated Organic Compound

EP2026028480A1 · Mar 18, 2026
Publication

1 H [1,2,3]Triazolo[4,5 H]Quinazoline Compounds As Protein Kinase Inhibitors

EP4711369A1 · Chengdu Cynogen Bio-Pharmaceutical Technology Co., Ltd. · Mar 18, 2026
Publication

Combinations Of Nanoparticle Loaded Immune Agonists And Ras Targeted Therapies For Treatment Of Cancer

EP4709736A2 · University of Massachusetts · Mar 18, 2026
Publication

Combination Therapy For Treatment Of Cancer

EP4709384A2 · PMV Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Dual Ezh2 Hsp90 Inhibitors

EP4709721A1 · Taipei Medical University · Mar 18, 2026
Publication

Decreasing The Intrinsically Disordered Protein Alpha Synuclein's Levels By Targeting Its Structured Mrna With A Ribonuclease Targeting Chimera

EP4709715A1 · University of Florida Research Foundation, Incorporated · Mar 18, 2026
Publication

Identification Of Host Factors And Compounds To Boost Viral Transduction

EP4709713A2 · University of Massachusetts · Mar 18, 2026
Publication

Inhibitors And Degraders Of Pip4 K Protein

EP4709720A1 · Larkspur Biosciences, Inc. · Mar 18, 2026
Publication

Ionizable Cationic Lipids For Rna Delivery

EP4709710A1 · Arcturus Therapeutics, Inc. · Mar 18, 2026
Publication

Hydrogel And Orexin Receptor Ligand Compositions And Methods Of Making And Using The Same

EP4709410A1 · Wake Forest University Health Sciences · Mar 18, 2026
Publication

Camptothecin Derivative, Linker, Ligand Drug Conjugate And Medical Use Thereof

EP4711371A1 · Gan &Amp Lee Pharmaceuticals Co., Ltd. · Mar 18, 2026
Publication

Tetrahydrocarbazole Derivative, Pharmaceutical Composition, And Use Thereof

EP4711356A1 · Nain Biotech (Hangzhou) Co., Ltd. · Mar 18, 2026
Publication

Inverse Agonists Of Rar Related Orphan Receptors (Rors)

EP4709383A1 · 11949098 Canada Inc. · Mar 18, 2026
Publication

Linker Compounds And Ligand Drug Conjugates, Preparation Methods And Uses Thereof

EP4709425A1 · Biocytogen Pharmaceuticals (Beijing) Co., Ltd. · Mar 18, 2026
Publication

Lipids And Lipid Like Compounds For Therapeutic Lipid Nanoparticle (Lnp) Delivery

EP4687854A2 · Sepia Therapeutics, Inc. · Mar 18, 2026
Publication

Nucleoside Analog For 5' Phosphonate Modification And Oligonucleotide Prepared Therefrom

EP4678646A1 · Shanghai Argo Biopharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Substituted Phenyl Oxooxazolyl Piperidine Dione Compounds

EP4568957A1 · Bristol-Myers Squibb Company · Mar 18, 2026
Publication

Negative Allosteric Modulators Of Glun2 B Receptors And Methods Of Making And Using The Same

EP2024197289A1 · Mar 18, 2026
Publication

A Method Of Using Simazine For Controlling Annual Bluegrass In Cool Season Turfgrasses

EP2024197286A1 · Mar 18, 2026
Publication

Targeting Lysosomal Lipid In Alzheimer's Disease

EP2024197271A1 · Mar 18, 2026
Publication

Novel Compounds As Cyp11 A1 Inhibitors And Methods Of Use Thereof

EP4709732A1 · Shenzhen Ionova Life Science Co., Ltd. · Mar 18, 2026
Publication

Isoquinolinone Derivatives And 4 H Quinolizinone Derivatives And Pharmaceutical Compositions Thereof For The Treatment Of Disease

EP4709711A1 · Beone Medicines I GmbH · Mar 18, 2026
Publication

Compositions For Modulation Of Il 2 And Methods Thereof

EP2024197238A2 · Mar 18, 2026
Publication

Adar1 Inhibitors And Uses Thereof

EP2024196863A1 · Mar 18, 2026
Publication

Development Of Highly Fluorogenic Styrene Probes For Visualizing Rna In Live Cells

EP2024196850A1 · Mar 18, 2026
Publication

Fabk Inhibitor Compositions

EP2024196830A1 · Mar 18, 2026
Publication

Sigma 1 Receptor Ligands And Use Thereof

EP2024196828A2 · Mar 18, 2026
Publication

Compounds And Constructs Useful For Targeting Fibroblast Activation Protein

EP2024196698A2 · Mar 18, 2026
Publication

Compounds And Constructs Useful For Targeting Fibroblast Activation Protein

EP2024196697A2 · Mar 18, 2026
Publication

Novel Compound And Organic Light Emitting Element Comprising Same

EP2024196207A1 · Mar 18, 2026
Publication

Compound Comprising Novel Polyester Linker And Use For Same

EP2024196139A1 · Mar 18, 2026
Publication

3 Clpro Inhibitors And Methods Thereof

EP4709731A1 · Agency for Science, Technology and Research · Mar 18, 2026
Publication

Solid Forms Of Mdm2 Degraders

EP2024197221A2 · Mar 18, 2026
Publication

Deuterated Mdm2 Degraders And Uses Thereof

EP2024197218A2 · Mar 18, 2026
Publication

Mdm2 Degraders And Uses Thereof

EP2024197216A2 · Mar 18, 2026
Publication

Arginine Vasopressin Receptor (Avpr) Antagonists And Methods Of Using Thereof

EP2024197124A2 · Mar 18, 2026
Publication

Sulfonium Compounds And Methods For Making And Using The Same

EP2024196978A2 · Mar 18, 2026
Publication

Compounds For Restoring Susceptibility To Beta Lactam Antibiotics

EP2024196958A2 · Mar 18, 2026
Publication

Compound And Organic Light Emitting Device Comprising Same

EP2024196084A1 · Mar 18, 2026
Publication

Nitrogen Including Heterocycle Derivative

EP2024195674A1 · Mar 18, 2026
Publication

Epoxy Resin, Curable Resin Composition, And Cured Product Thereof

EP2024195581A1 · Mar 18, 2026
Publication

Imidazolidine Derivative Or Pharmaceutically Acceptable Salt Thereof, And Use Thereof

EP2024196047A1 · Mar 18, 2026
Publication

Method For Producing 4 [N (5,6 Diphenylpyrazin 2 Yl) N Isopropylamino] 1 Butanol

EP2024195447A1 · Mar 18, 2026
Publication

Method For Producing 4 [N (5,6 Diphenylpyrazin 2 Yl) N Isopropylamino] 1 Butanol Crystal

EP2024195446A1 · Mar 18, 2026
Publication

Photoelectric Conversion Element

EP2024195391A1 · Mar 18, 2026
Publication

Solid Forms Of Roxadustat With Camphorsulfonic Acid

EP2024194828A1 · Mar 18, 2026
Publication

Process For Preparation Of Pyroxasulfone And Intermediates Thereof

EP2024194794A1 · Mar 18, 2026
Publication

Improved Compositions

EP2024194781A1 · Mar 18, 2026
Publication

Compound, Composition, Cured Product, And Pattern

EP2024195504A1 · Mar 18, 2026
Publication

Triazolopyrimidine Compound

EP2024193716A1 · Mar 18, 2026
Publication

Triazine Compound And Use Thereof

EP2024193699A1 · Mar 18, 2026
Publication

Pyridinopyrrole Derivative And Use Thereof In Drugs

EP2024193689A1 · Mar 18, 2026
Publication

Cdk Inhibitor

EP2024193640A1 · Mar 18, 2026
Publication

Method For Extracting Flavone From Bamboo Leaves And Use Thereof

EP2024193625A1 · Mar 18, 2026
Publication

Spiro Compound, And Pharmaceutical Composition Thereof, Preparation Method Therefor And Use Thereof

EP2024193575A1 · Mar 18, 2026
Publication

Pyrrolo[2,3 C]Pyridine Compound As Bromodomain Inhibitor

EP2024193527A1 · Mar 18, 2026
Publication

Benzoyl Pyrrolopyrimidine Derivative, And Use Thereof And Preparation Method Therefor

EP2024193509A1 · Mar 18, 2026
Publication

Method For Preparing Pyrrolopyrimidine Compound Or Pharmaceutically Acceptable Salt Thereof

EP2024193496A1 · Mar 18, 2026
Publication

Fumarate Crystal Form Of Jak Tyrosine Kinase Inhibitor, Preparation Method Therefor, And Application Thereof

EP2024193495A1 · Mar 18, 2026
Publication

Nitrogen Containing Tricyclic Derivative And Use Thereof In Medicine

EP2024193464A1 · Mar 18, 2026
Publication

Sulfine Based Compounds For Generating Hydrogen Persulfide

EP2024192321A2 · Mar 18, 2026
Publication

3 Alkylamine Indole Activators Of Serotonin Receptors

EP4680236A2 · ATAI Therapeutics, Inc. · Mar 18, 2026
Publication

Bicyclic Derivatives, Compositions And Uses Thereof

EP2024193683A1 · Mar 18, 2026
Publication

Organic Electronic Element And Compound

EP2024190394A1 · Mar 18, 2026
Publication

Preparation Method Of Pyrrolotriazine Compound

EP2024193457A1 · Mar 18, 2026
Publication

Shp2 Phosphatase Allosteric Inhibitors

EP2024193439A1 · Mar 18, 2026
Publication

Crystal Form Of Heteropyridopyrimidinone Derivative And Preparation Method Therefor

EP2024193393A1 · Mar 18, 2026
Publication

Indazole Substituted Podophyllotoxin Derivative, Preparation Method Therefor, And Use Thereof

EP2024193328A1 · Mar 18, 2026
Publication

Isochromane Compounds As Well As Pharmaceutical Composition Thereof And Use Thereof

EP2024193313A1 · Mar 18, 2026
Publication

Chemical Coupling Linker And Use Thereof

EP4674840A1 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Resist Composition, Resist Pattern Formation Method, Compound, And Acid Diffusion Control Agent

EP2024190919A1 · Mar 18, 2026
Publication

Compound, Material For Organic Electroluminescent Element, Organic Electroluminescent Element, And Electronic Device

EP2024190882A1 · Mar 18, 2026
Publication

Method For Manufacturing Ethylene Carbonate

EP2024190880A1 · Mar 18, 2026
Publication

Compounds, Compositions, And Methods For Treating, Ameliorating, And/Or Preventing Pain

EP2024173873A2 · Mebias Discovery, Inc. · Mar 18, 2026
Publication

Proteolysis Targeting Chimera (Protac) Compounds And Uses Thereof Field

EP2024165050A1 · Aubrak Therapeutics · Mar 18, 2026
Publication

An Improved Process For The Preparation Of Intermediates Used In The Preparation Of Dasatinib

EP2024189532A1 · Mar 18, 2026
Publication

Kif18 A Inhibitor

EP2024188338A1 · Mar 18, 2026
Publication

Tricyclic Compound, And Preparation And Application Thereof

EP2024188214A1 · TYK Medicines, Inc. · Mar 18, 2026
Publication

Phosphor For Detecting Fire Blight Pathogen And Use Thereof

EP4656632A1 · UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY · Mar 18, 2026
Publication

5 Cyano 1 H Imidazole 2 Carboxamide Compounds As Csf1 R Inhibitors

EP4709719A1 · Modulo Bio, Inc. · Mar 18, 2026
Publication

Heteroaryl Compounds As Ligand Directed Degraders Of Irak4

EP4709730A1 · Celgene Corporation · Mar 18, 2026
Publication

Heteroaryl Compounds As Ligand Directed Degraders Of Irak4

EP4709486A1 · Celgene Corporation · Mar 18, 2026
Publication

Heteroaryl Compounds As Ligand Directed Degraders Of Irak4

EP4709389A1 · Celgene Corporation · Mar 18, 2026
Publication

Methods And Compositions For Targeted Protein Degradation

EP4709727A1 · Ranok Therapeutics (Hangzhou) Co. Ltd. · Mar 18, 2026
Publication

Crystalline Forms Of 2 [3 (2,2,6,6 Tetramethylpiperidin 4 Yl) 3 H [1,2,3]Triazolo[4,5 C]Pyridazin 6 Yl] 5 (2 H 1,2,3 Triazol 2 Yl)phenol

EP4709478A1 · PTC THERAPEUTICS, HD, INC. · Mar 18, 2026
Publication

Parp1 Inhibitor Compounds

EP4709381A1 · Duke Street Bio Limited · Mar 18, 2026
Publication

Anticonvulsive Compounds And Uses Thereof

EP4709724A1 · Jazz Pharmaceuticals Research UK Limited · Mar 18, 2026
Publication

Polymorphic Forms And Formulations Of Leriglitazone

EP4709476A2 · Minoryx Therapeutics S.L. · Mar 18, 2026
Publication

Macrocyclic Compounds As Usp1 Inhibitors

EP2024146541A1 · Guangdong Newopp Biopharmaceuticals Co., Ltd. · Mar 18, 2026
Publication

Gsk3 A Inhibitors And Methods Of Use Thereof

EP4709712A1 · Blueprint Medicines Corporation · Mar 18, 2026
Publication

6 Substituted 3 Phenyl Isoindolin 1 Ones As Cbl B Inhibitors Selective Over C Cbl

EP4709718A1 · Genentech Inc. · Mar 18, 2026
Publication

New 5 H Pyrrolo[3,2 B:5,4 C']Dipyridine Derivatives And 6,7,8,9 Tetrahydro 5 H Pyrrolo[3,2 B:5,4 C']Dipyridine Useful In The Treatment Of Cancer

EP4709483A1 · Institut Regional du Cancer de Montpellier · Mar 18, 2026
Publication

Compounds And Uses Thereof

EP4709726A1 · Foghorn Therapeutics Inc. · Mar 18, 2026
Publication

Substituted Quinoxalines

EP4709714A1 · Mirati Therapeutics, Inc. · Mar 18, 2026
Publication

5,6 Fused And 6,6 Fused Bicyclic Alcohols And Ethers And Compositions For Use As 15 Prostaglandin Dehydrogenase Modulators

EP4709481A1 · Amgen Inc. · Mar 18, 2026
Publication

Antagonists Of N Methyl D Aspartate Receptors And Use Thereof

EP4709707A1 · Fakultní Nemocnice Hradec Králové · Mar 18, 2026
Publication

Pyrazolo[4,3 F]Quinazoline Derivatives As Modulators Of G12 D Mutant Kras Useful For The Treatment Of Cancer

EP4709729A1 · Jazz Pharmaceuticals Ireland Ltd. · Mar 18, 2026
Publication

Isoxazolidines As Ripk1 Inhibitors And Use Thereof

EP4709723A1 · GENZYME CORPORATION · Mar 18, 2026
Publication

Isoxazolidines As Ripk1 Inhibitors And Use Thereof

EP4709716A1 · GENZYME CORPORATION · Mar 18, 2026
Publication

Isoxazolidines As Ripk1 Inhibitors And Use Thereof

EP4709722A1 · GENZYME CORPORATION · Mar 18, 2026
Publication

Novel Phenylpyrazole Insecticide Compounds And Compositions

EP4709728A1 · Molecular Horizon S.r.l. · Mar 18, 2026
Publication

Novel Carboxamide Derivatives

EP4709708A1 · ANGELINI PHARMA S.P.A. · Mar 18, 2026
Publication

5,6 Fused Bicyclic Amides And Compositions For Use As 15 Prostaglandin Dehydrogenase Modulators

EP4709480A1 · Amgen Inc. · Mar 18, 2026
Publication

6,6 Fused Bicyclic Amides And Compositions For Use As 15 Prostaglandin Dehydrogenase Modulators

EP4709479A1 · Amgen Inc. · Mar 18, 2026
Publication

Heterocyclic Compounds And Uses Thereof

EP4709725A1 · Progentos Therapeutics, Inc. · Mar 18, 2026
Publication

Chlorotonil Derivatives

EP4709717A1 · Helmholtz-Zentrum für Infektionsforschung GmbH · Mar 18, 2026
Publication

Use Of Fenpyroximate For Controlling Earth Mites, Ground Pearls And Eriophyidaes

EP2024194869A1 · Mar 18, 2026
Publication

Pyrimido[4,5 B][1,5]Naphthyridine 4,5(3 H,10 H) Dione Derivatives For The Treatment Of Diseases Associated With Ptc Mutations, Such As E.G. Cancer

EP2024194607A1 · Mar 18, 2026
Publication

Modulating The Innate Immunity Of Rna

EP2024194756A1 · Mar 18, 2026
Publication

Broad Spectrum Antifungal Keto Alkyl Pyridinium Compounds

EP2024197165A1 · Mar 18, 2026
Publication

3 ((1,1 Dioxido 2,3,4,5 Tetrahydrobenzo[F][1,2,5]Thiadiazepin 8 Yl)oxy) 2 Fluoroacrylic Acid Derivatives As Sodium Taurocholate Co Transporting Polypeptide (Ntcp) Inhibitors For The Treatment Of Cholestasis

EP2024163962A1 · Hemoshear Therapeutics, Inc. · Mar 18, 2026
Publication

Herbicidal Triazine Derivatives

EP2024194063A1 · Mar 18, 2026
Publication

Multicomponent Complexes, Including Salts And Crystalline Complexes, Of Ent1 Inhibitors

EP2024194392A1 · Mar 18, 2026
Publication

Bio Based N Hydroxypyridone Compounds

EP2024189119A1 · Mar 18, 2026
Publication

Method For The Separation Of Phosphorus Stereoisomers Of Remdesivir Using Liquid Liquid Chromatography

EP4709498A1 · RotaChrom Technológiai Zrt. · Mar 18, 2026
Publication

Hydroquinazoline Derivatives For The Treatment Of A Disease Or Disorder

EP4673431A1 · Novartis AG · Mar 18, 2026
Publication

Assays For Diagnosing And Evaluating Treatment Options For Fabry Disease

EP4541418A2 · Amicus Therapeutics, Inc. · Mar 18, 2026
Publication

Heterocycles For Organic Electroluminescent Devices

EP4652169A1 · UDC Ireland Limited · Mar 18, 2026
Publication

Kinase Inhibitors For The Treatment Of Central And Peripheral Nervous System Disorders

EP4574153A2 · University of Miami · Mar 18, 2026
Publication

Compounds That Participate In Cooperative Binding And Uses Thereof

EP4545521A2 · Revolution Medicines, Inc. · Mar 18, 2026
Publication

Ikaros Zinc Finger Family Degraders And Uses Thereof

EP4464703A2 · Gilead Sciences, Inc. · Mar 18, 2026
Publication

Use Of Compounds For Treating Hk2 Expressing Cancers

EP4464334A2 · VIDAC Pharma Ltd. · Mar 18, 2026
Publication

Rho Kinase Inhibitor Ba 1049 (R) And Active Metabolites Thereof

EP4509138A2 · BioAxone BioSciences, Inc. · Mar 18, 2026
Publication

Substituted Heterocyclic Compounds And Therapeutic Uses Thereof

EP4509122A2 · Bayer Aktiengesellschaft · Mar 18, 2026
Publication

N (Phenyl) 5 (Heteroaryl) 1 H Pyrazol 3 Amine Derivatives As Tnik Inhibitors For Use In The Treatment Of Cancer

EP4477271A2 · Korea Research Institute of Chemical Technology · Mar 18, 2026
Publication

Synthesis Of Cantharidin

EP4339199A2 · Verrica Pharmaceuticals Inc. · Mar 18, 2026
Publication

Adenosine Receptor Antagonists And Uses Thereof

EP4364727A2 · Teon Therapeutics, Inc. · Mar 18, 2026
Publication

Tyk2 Inhibitors And Uses Thereof

EP4438117A2 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Choline Salt Forms Of An Hiv Capsid Inhibitor

EP4382105A2 · Gilead Sciences, Inc. · Mar 18, 2026
Publication

Novel Ionizable Lipid And Lipid Nanoparticle Composition Using Same

EP2024195922A1 · Mar 18, 2026
Publication

Use Of Small Molecule Compound Having Naphthylamine Structure

EP2024192873A1 · Mar 18, 2026
Publication

Compound For Photolithographic Dielectric Composition, Polymer, And Photolithographic Dielectric Composition

EP2024187508A1 · Mar 18, 2026
Publication

Balasubramide Derivative And Use Thereof In Preparation Of Drug For Treating Acute Lung Injury

EP2024183123A1 · Guangdong Pharmaceutical University · Mar 18, 2026
Publication

A New Copper(ii) Complex Containing 5 Fluorouracil And Terpyridine With Anticancer And Antiangiogenic Effects

EP4626897A1 · Istinye Üniversitesi · Mar 18, 2026
Publication

Compound, And Preparation Method Therefor And Use Thereof In Preparation Of Seh Inhibitor And Ppars Agonist

EP4563573A1 · Kunming Yuanrui Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Cathepsin L Inhibitors

EP4619388A1 · Biofront Therapeutics (Beijing) Co., Ltd. · Mar 18, 2026
Publication

Chemiluminescent Reagent For Detecting Mercaptan, Synthesis Method, And Use

EP2024152296A1 · Kunming University of Science and Technology · Mar 18, 2026
Publication

Substituted Heterocyclic Compound Derivatives And Their Pharmaceutical Use

EP4634192A1 · Avelos Therapeutics Inc. · Mar 18, 2026
Publication

Novel Lipid Compound And Lipid Nanoparticle Composition Comprising Same

EP4635939A1 · Korea Institute of Science and Technology · Mar 18, 2026
Publication

Methods For Treating Patients With Hematologic Malignancies

EP4630122A1 · Aptose Biosciences Inc. · Mar 18, 2026
Publication

Metastable Free Lanthanide Based Contrast Agents And Method

EP4633682A1 · Inventure, LLC · Mar 18, 2026
Publication

Compounds And Compositions As C Kit Kinase Inhibitors

EP4630423A1 · Third Harmonic Bio, Inc. · Mar 18, 2026
Publication

Preparation And Application Of Novel Biaryl Ring Compound As Immunomodulator

EP2024125662A1 · Shanghai Longwood Biopharmaceuticals Co., Ltd. · Mar 18, 2026
Publication

Crystal Form Of Proximod, Preparation Method Therefor, And Use Thereof

EP4635945A1 · Jiankuan (Suzhou) Biotechnology Co., Ltd · Mar 18, 2026
Publication

Substituted Tetrahydrocyclopentyl[C]Pyrrole Derivative, Preparation Method, Intermediate And Use Thereof

EP4635949A1 · Jiangsu NHWA Pharmaceutical Co., Ltd · Mar 18, 2026
Publication

Novel Tricyclic Compound As Kras G12 D Inhibitor, And Use Thereof

EP4631948A1 · SK Biopharmaceuticals Co., Ltd. · Mar 18, 2026
Publication

Novel 2 ((Trans 4 (4 Aryloxy)cyclohexyl)amino)quinazolinone Derivative And Method For Preparing Same

EP4631933A1 · NexThera Co., Ltd. · Mar 18, 2026
Publication

Crystalline Forms Of Lanraplenib And Methods Of Making And Using The Same

EP4646412A1 · Kronos Bio, Inc. · Mar 18, 2026
Publication

Compounds And Compositions As C Kit Kinase Inhibitors

EP4630424A1 · Third Harmonic Bio, Inc. · Mar 18, 2026
Publication

Fluorine Containing Isoxazole Compound And Method For Producing Same

EP4631934A1 · Unimatec Co., Ltd. · Mar 18, 2026
Publication

Bifunctional Compounds And Pharmaceutical Uses Thereof

EP4630422A1 · Risen (Suzhou) Pharma Tech Co., Ltd. · Mar 18, 2026
Publication

Plk1 Degradation Inducing Compounds With Increased Rigidity

EP4626889A1 · Uppthera, Inc. · Mar 18, 2026
Publication

Jak Inhibitors, Pharmaceutical Compositions, And Therapeutic Applications

EP4626886A1 · OnQuality Pharmaceuticals China Ltd. · Mar 18, 2026
Publication

Nitrogen Containing Heterocycle With Serotonin Receptor Binding Activity And Carbocyclic Derivative

EP4631938A1 · Shionogi & Co., Ltd · Mar 18, 2026
Publication

Pyrrolo[3,2 D]Pyrimidin 4 One Derivative, And Preparation Method Therefor And Medical Use Thereof

EP4624473A1 · Shenzhen Salubris Pharmaceuticals Co., Ltd. · Mar 18, 2026
Publication

Hdac Inhibitor And Use Thereof

EP4631931A1 · Wigen Biomedicine Technology (Shanghai) Co., Ltd. · Mar 18, 2026
Publication

Crystalline Form Or Amorphous Form Of Oxoisoindole 5 Formamide Compound Or Salt And Solvate Thereof

EP4631937A1 · Hangzhou Glubio Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Fused Cyclic Compounds And Use Thereof

EP4630429A1 · Jacobio Pharmaceuticals Co., Ltd. · Mar 18, 2026
Publication

Thyroid Hormone ß Receptor Agonist, Crystal Form, Preparation Method And Use

EP4631943A1 · KPC PHARMACEUTICALS, INC · Mar 18, 2026
Publication

Compound Targeting Pan Kras Protein Degradation Agent And Use Thereof

EP4631940A1 · Betta Pharmaceuticals Co., Ltd. · Mar 18, 2026
Publication

Benzothiazole Pyrimidineamine Dyrk2 Inhibitor, Preparation Method Therefor, And Use Thereof

EP4631941A1 · Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Compound, Nanoparticles, Medicine And Method For Producing Nanoparticles

EP4631949A1 · Japan Science and Technology Agency · Mar 18, 2026
Publication

Salt Forms Of Irak4 Degraders

EP4602042A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Pkmyt1 Inhibitor, Preparation Method Therefor, And Pharmaceutical Composition And Use Thereof

EP4624471A1 · Shanghai Qilu Pharmaceutical Research and Development Centre Ltd. · Mar 18, 2026
Publication

Ultra Small Stable Platinum Cobalt Nanoparticle Catalyst, And Preparation Method Therefor And Use Thereof In Selective Hydrogenation

EP2024109834A1 · Mar 18, 2026
Publication

Cdk2 Inhibitors And Uses Thereof

EP4573094A2 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Cucurbituril Compound And Medical Use Thereof

EP4617274A1 · Shanghai Senhui Medicine Co., Ltd. · Mar 18, 2026
Publication

Tgf Beta Inhibitor Compound And Use Thereof

EP4556478A1 · Medinno Pharmaceutical Technology (Zhuhai) Co., Ltd. · Mar 18, 2026
Publication

Tgf Beta Inhibitor Compound And Use Thereof

EP4556477A1 · Medinno Pharmaceutical Technology (Zhuhai) Co., Ltd. · Mar 18, 2026
Publication

Spirochiral Platinum(ii) And Palladium(ii) Complex Circularly Polarized Luminescent Material And Use Thereof

EP2024022294A1 · Zhejiang University of Technology · Mar 18, 2026
Publication

Camptothecin Derivative, Method For Preparing Same, And Use Thereof

EP4541797A1 · Hangzhou Adcoris Biopharma Co., Ltd · Mar 18, 2026
Publication

Carbonic Anhydrase Enzyme Inhibitors And Methods Of Use Thereof

EP4630401A2 · Rutgers, the State University of New Jersey · Mar 18, 2026
Publication

Rbm39 Sulfonamide Inhibitors

EP4634155A1 · Recursion Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Phosphorus Containing Compound, And Preparation Method Therefor And Pharmaceutical Use Thereof

EP2024067783A1 · Shanghai Jemincare Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Pyrimidine Fused Ring Compound, Preparation Method Therefor, And Use Thereof

EP2024061365A1 · Origiant Pharmaceutical Co., Ltd · Mar 18, 2026
Publication

Solid Forms Of A Sgc Activator

EP4630113A1 · Boehringer Ingelheim International GmbH · Mar 18, 2026
Publication

Compound Used As Cdk4 Inhibitor And Use Thereof

EP2024012543A1 · TYK Medicines, Inc. · Mar 18, 2026
Publication

Compounds For Treating Cancer

EP4630428A1 · Genesis Therapeutics, Inc. · Mar 18, 2026
Publication

Compound, Light Emitting Element, Display Device, And Lighting Device

EP4559914A1 · Toray Industries, Inc. · Mar 18, 2026
Publication

Inhibitory Compounds

EP4633735A1 · Storm Therapeutics Ltd · Mar 18, 2026
Publication

Cyclen Based Compounds And Their Gd(iii) Complexes For Use As Multimodal Pet/Mri Contrast Agents

EP4619048A1 · Ustav Organicke Chemie a Biochemie AV CR v.v.i. · Mar 18, 2026
Publication

Polq Inhibitors

EP4630410A1 · Astrazeneca AB · Mar 18, 2026
Publication

Aminopyrimidine Compounds And Use Thereof

EP2023241618A1 · Medshine Discovery Inc. · Mar 18, 2026
Publication

Compounds For The Treatment Of Centra Nervous System Disorders

EP4630117A1 · Autifony Therapeutics Limited · Mar 18, 2026
Publication

Solid State Forms Of Zipalertinib And Process For Preparation Thereof

EP4630120A1 · Assia Chemical Industries Ltd. · Mar 18, 2026
Publication

Cyclic Imides And Adhesive Compositions Including Them

EP4634157A1 · 3M Innovative Properties Company · Mar 18, 2026
Publication

Cocrystals Of Odevixibat

EP4630112A1 · Albireo AB · Mar 18, 2026
Publication

Therapeutic Compounds

EP4630115A1 · Sanofi · Mar 18, 2026
Publication

Synthesis Of Sulfoximine Compounds Having A Stereogenic Sulfur Atom

EP4630421A1 · Syngenta Crop Protection AG · Mar 18, 2026
Publication

Materials For Electronic Devices

EP4634166A1 · Merck Patent GmbH · Mar 18, 2026
Publication

Novel Compounds As Modulators Of Nlrp3 Inhibition

EP4630417A1 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

Sulfonyl Derivatives As Ccr6 Inhibitors

EP4630402A1 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

Novel Substituted Pyrazine Carboxamide Imidazopyridine Derivatives

EP4630419A1 · Boehringer Ingelheim International GmbH · Mar 18, 2026
Publication

Heterocyclic Inhibitors Of Kras G12 C Mutant Proteins And Uses Thereof

EP4598917A1 · Amgen Inc. · Mar 18, 2026
Publication

Process For The Preparation Of Sitagliptin

EP4630568A1 · KRKA, D.D., Novo Mesto · Mar 18, 2026
Publication

Thiadiazolyl Derivatives As Dna Polymerase Theta Inhibitors And Uses Thereof

EP4630119A1 · GlaxoSmithKline Intellectual Property (No.4) Limited · Mar 18, 2026
Publication

Formulation For Aromatizing A Food Product

EP4630411A1 · Döhler GmbH · Mar 18, 2026
Publication

Polyoxyalkylene 1,2 Dimyristoyl Glycerol Compounds, Wherein The Polyoxyalkylene Is A Poly(ethylene Oxide) Having C1 To C3 Alkyloxymethyl Side Chains

EP4619454A1 · Evonik Operations GmbH · Mar 18, 2026
Publication

Novel N,N Dimethyltryptamine (Dmt) Derivatives And Uses Thereof

EP4630400A1 · MiHKAL GmbH · Mar 18, 2026
Publication

A Process For Preparing Pure (3 S) Pyrrolidin 3 Ol And Pure (3 S) Pyrrolidin 3 Ol Hydrochloride

EP4630425A1 · Bayer Consumer Care AG · Mar 18, 2026
Publication

Targeted Protein Degradation Using Prodrugs Of Bifunctional Compounds That Bind Ubiquitin Ligase And Target Mcl 1 Protein

EP4630415A1 · Captor Therapeutics S.A. · Mar 18, 2026
Publication

Targeted Protein Degradation Using Bifunctional Compounds That Bind Ubiquitin Ligase And Target Mcl 1 Protein

EP4630414A1 · Captor Therapeutics S.A. · Mar 18, 2026
Publication

Glucagon Like Peptide 1 Receptor Agonists

EP4615573A1 · Eli Lilly and Company · Mar 18, 2026
Publication

Processes For Making Endochin Like Quinolones From Alkyl 3 (3 Alkoxyphenyl)amino) 2 (4 (4 Alkoxy)phenoxy)phenyl)but 2 Enoate

EP4630409A1 · Intervet International B.V. · Mar 18, 2026
Publication

Processes For Making Endochin Like Quinolones From Alkyl 3 (3 Alkoxyphenyl)amino) 2 (4 (4 Alkoxy)phenoxy)phenyl)but 2 Enoate

EP4630408A1 · Intervet International B.V. · Mar 18, 2026
Publication

Process For The Preparation Of Belumosudil Mesylate And Its Crystalline Form

EP4499600A1 · Alivus Life Sciences Limited · Mar 18, 2026
Publication

2 [(2 Oxo 4 Phenyl 2 H Chromen 7 Yl)oxy] Propanamido Derivatives

EP4499622A1 · Lunella Biotech, Inc. · Mar 18, 2026
Publication

Nlrp3 Inflammasome Inhibitors

EP4499646A1 · Hangzhou Highlightll Pharmaceutical Co., Ltd · Mar 18, 2026
Publication

Solid Forms Of Tyk2 Inhibitors And Methods Of Use

EP4499645A1 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Indolizine Compounds For The Treatment Of Mental Disorders Or Inflammation

EP4499058A2 · Tactogen Inc. · Mar 18, 2026
Publication

Compositions And Methods For Treating Cancer

EP4499625A1 · A2A Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Inhibitors Of Interactions Between Trf1 Tin2 Or Trf2 Tin2 Telomeric Proteins For Use In Anticancer Therapy

EP4508048A1 · Politechnika Gdanska · Mar 18, 2026
Publication

Inhibitors Of Nlrp3

EP4630420A1 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

New Cyanopyridine Khk Inhibitor Compounds

EP4630114A1 · Boehringer Ingelheim International GmbH · Mar 18, 2026
Publication

Crystalline Adipic Acid Salt Form Of A Ccr6 Antagonist

EP4630118A1 · Idorsia Pharmaceuticals Ltd · Mar 18, 2026
Publication

Dimeric Compounds As Inhibitors Of Glycogen Synthase 1 (Gys1) And Methods Of Use Thereof

EP4587118A1 · Maze Therapeutics, Inc. · Mar 18, 2026
Publication

Therapeutic Agent For Respiratory Disease

EP4501326A1 · The Jikei University · Mar 18, 2026
Publication

Methods And Compositions For Modulating Kras(g12 D)

EP2024044334A2 · Ranok Therapeutics (Hangzhou) Co. Ltd. · Mar 18, 2026
Publication

Organic Compounds

EP4493559A2 · Intra-Cellular Therapies, Inc. · Mar 18, 2026
Publication

Organic Compounds

EP4493560A2 · Intra-Cellular Therapies, Inc. · Mar 18, 2026
Publication

Nlrp3 Modulators

EP4493556A1 · Zomagen Biosciences Ltd · Mar 18, 2026
Publication

Processes For The Preparation Of Substituted Spirooxindole Derivatives

EP4493561A1 · Enanta Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Method For Recovering Ionic Liquid

EP4495104A1 · National University Corporation Kanazawa University · Mar 18, 2026
Publication

Method For Recovering Ionic Liquid

EP4495103A1 · National University Corporation Kanazawa University · Mar 18, 2026
Publication

Deuterated Heterocyclic Ketone Compound And Use Thereof

EP4509501A1 · Hinova Pharmaceuticals Inc. · Mar 18, 2026
Publication

Polycyclic Quinazolines For Inhibition Of Erbb2

EP4587124A1 · Enliven Inc. · Mar 18, 2026
Publication

3 (1 H Indole 2 Carbonyl) 6,6 Dimethyl N ((S) 1 Oxo 3 ((S) 2 Oxopyrrolidin 3 Yl)p Ropan 2 Yl) 3 Azabicyclo[3.1.0]Hexane 2 Carboxamide Derivatives As Mpro Inhibitors For The Treatment Of Coronavirus Infections

EP4587433A1 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Lrrk2 Inhibitors

EP4504722A2 · Brenig Therapeutics, Inc. · Mar 18, 2026
Publication

Novel Process And Intermediate For The Preparation Of Apalutamide

EP4504715A1 · BDR Lifesciences Private Limited · Mar 18, 2026
Publication

Salt Form And Crystal Form Of Vanin Enzyme Inhibitor, Method For Preparing Same, And Use Thereof

EP4495120A1 · Shanghai Meiyue Biotech Development Co., Ltd. · Mar 18, 2026
Publication

Pyrazole Membrane Associated Tyrosine And Threonine Specific Cdc2 Inhibitory Kinase (Pkmyt1) Inhibitors And Uses Thereof

EP4493557A1 · Insilico Medicine IP Limited · Mar 18, 2026
Publication

Non Aromatic Cyclic Pyrimidine Analogs As Glucosylceramide Synthase Inhibitors

EP4490148A2 · Merck Sharp & Dohme LLC · Mar 18, 2026
Publication

Triazine Compound, Intermediate Thereof, Preparation Method Therefor And Use Thereof

EP4491623A1 · JKT Biopharma Co., Ltd. · Mar 18, 2026
Publication

Acetal Type Releasable Polyoxyethylene Derivative, Production Method Thereof And Acetal Type Releasable Polyoxyethylene Conjugate

EP4512845A1 · NOF Corporation · Mar 18, 2026
Publication

Fap Inhibitors

EP4511367A1 · Shanghai Sinotau Biotech. Co., Ltd · Mar 18, 2026
Publication

Cooling Processes To Produce Acfc With Increased Crystal Size With Purge

EP4508041A1 · Eastman Chemical Company · Mar 18, 2026
Publication

Inhibitors Of Kif18 A And Uses Thereof

EP4572855A1 · Accent Therapeutics, Inc. · Mar 18, 2026
Publication

Adenosine Ligands For The Treatment Of Neurological Disorders

EP4479399A1 · Lucy Therapeutics, Inc. · Mar 18, 2026
Publication

Ortho Substituted Difunctional Bio Benzoxazine Compounds, Preparation Methods And Uses Thereof

EP4565580A1 · Jones, Paul · Mar 18, 2026
Publication

2 Amino Pyrido[2,3 D]Pyrimidin 7(8 H) One And 7 Amino 1 Pyrimido[4,5 D]Pyrimidin 2(1 H) One Derivatives Derivatives As Egfr Inhibitors For The Treatment Of Cancer

EP4612148A1 · Cancer Research Technology Limited · Mar 18, 2026
Publication

Cdk Inhibitors, Pharmaceutical Compositions, And Therapeutic Applications

EP4514796A1 · OnQuality Pharmaceuticals China Ltd. · Mar 18, 2026
Publication

Novel Ruthenium Complexes, Method Of Their Synthesis, Intermediate Compounds Used In This Method, Method Of Their Synthesis And The Use Of Novel Ruthenium Complexes In Olefin Metathesis Reactions

EP4543894A1 · Uniwersytet Warszawski · Mar 18, 2026
Publication

Crystal Of Substituted Piperidine Compound, Salts Of Substituted Piperidine Compound, And Crystals Thereof

EP4438602A1 · Eisai R&D Management Co., Ltd. · Mar 18, 2026
Publication

Diaryl Compound As Tubulin/Src Dual Target Inhibitor

EP4464700A1 · Wuhan Humanwell Innovative Drug Research and Development Center Limited Company · Mar 18, 2026
Publication

Herbicidal Pyrazole Compounds

EP4581022A1 · Syngenta Crop Protection AG · Mar 18, 2026
Publication

Process For The Preparation Of Substituted Pyrrolopyrimidines And Intermediates

EP4577548A1 · Astrazeneca AB · Mar 18, 2026
Publication

Inhibitors Of Myeloperoxidase

EP4573096A1 · Astrazeneca AB · Mar 18, 2026
Publication

Prodrugs Of Stat3 Inhibitors

EP4539936A1 · Tvardi Therapeutics, Inc. · Mar 18, 2026
Publication

Modified Amino Acids And Uses Thereof

EP4543901A2 · University of Strathclyde · Mar 18, 2026
Publication

Deuterated Organic Compounds And Uses Thereof

EP4460490A1 · Engrail Therapeutics, Inc. · Mar 18, 2026
Publication

Spleen Tyrosine Kinase Inhibitors And Methods Of Use Thereof

EP4532469A1 · THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS · Mar 18, 2026
Publication

Nucleic Acid Delivery Material

EP4477753A1 · National University Corporation Tokai National Higher Education and Research System · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4472967A2 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Bicyclic Amides And Esters For Controlling Invertebrate Pests

EP2023097341A2 · Mar 18, 2026
Publication

Ionic Liquid Based Formulations For The Prevention Or Treatment Of Neurological Diseases

EP4469044A1 · Universidade de Aveiro · Mar 18, 2026
Publication

Compounds And Methods Useful For Stabilizing Phenylalanine Hydroxylase Mutations

EP4486442A1 · Agios Pharmaceuticals, Inc. · Mar 18, 2026
Publication

(4 Benzo[D]Oxazol 2 Yl) 6,7 Dihydro 1 H Imidazo[4,5 C]Pyridine 5(4 H) Yl)methanone Derivatives As Mutant Pah Stabilizers For The Treatment Of Phenylketonuria

EP4486744A1 · Agios Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Compounds And Methods Useful For Stabilizing Phenylalanine Hydroxylase Mutations

EP4486447A1 · Agios Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Compounds And Methods Useful For Stabilizing Phenylalanine Hydroxylase Mutations

EP4486749A1 · Agios Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Compounds And Methods Useful For Stabilizing Phenylalanine Hydroxylase Mutations

EP4486446A1 · Agios Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Organic Compound, Organic Light Emitting Diode And Organic Light Emitting Device Having The Compound

EP4389851A1 · LG Display Co., Ltd. · Mar 18, 2026
Publication

Solid Forms Of Ceftolozane

EP4327828A2 · Merck Sharp & Dohme LLC · Mar 18, 2026
Publication

Compounds With An Acceptor And A Donor Group

EP4271163A2 · Merck Patent GmbH · Mar 18, 2026
Publication

Crystalline Forms Of N (4 (4 (Cyclopropylmethyl) Piperazine 1 Carbonyl)phenyl)quinoline 8 Sulfonamide

EP4285904A2 · Agios Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Substituted 4 Aminoisoindoline 1,3 Dione Compounds And Processes For Their Preparation

EP4272737A2 · Celgene Corporation · Mar 18, 2026
Publication

Synthesis Method Of Furoimidazopyridine Compound, Crystal Form Of Furoimidazopyridine Compound, And Crystal Form Of Salt Thereof

EP4248967A2 · Hangzhou Highlightll Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Synthesis Method Of Furoimidazopyridine Compound, Crystal Form Of Furoimidazopyridine Compound, And Crystal Form Of Salt Thereof

EP4248966A2 · Hangzhou Highlightll Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Crystalline Forms Of (2 R,5 S,13 Ar) 8 Hydroxy 7,9 Dioxo N (2,4,6 Trifluorobenzyl) 2,3,4,5,7,9,13,13 A Octahydro 2,5 Methanopyrido [1',2':4,5]Pyrazino [2,1 B][1,3]Oxazepine 10 Carboxamide

EP4309736A2 · Gilead Sciences, Inc. · Mar 18, 2026
Publication

Azolopyrimidine For The Treatment Of Cancer Related Disorders

EP4310082A2 · Arcus Biosciences, Inc. · Mar 18, 2026
Publication

Alkyl Chain Modified Imidazoquinoline Derivatives As Tlr7/8 Agonists And Uses Thereof

EP4257198A2 · Dynavax Technologies Corporation · Mar 18, 2026
Publication

Organotin Catalysts In Esterification Processes Of Furan 2,5 Dicarboxylic Acid (Fdca)

EP4253370A2 · Archer Daniels Midland Company · Mar 18, 2026
Publication

Lipid Nanoparticles

EP4332087A1 · Beijing Jitai Life Sciences Ltd. · Mar 18, 2026
Publication

Novel 6 6 Bicyclic Aromatic Ring Substituted Nucleoside Analogues For Use As Prmt5 Inhibitors

EP4219496A1 · JANSSEN Pharmaceutica NV · Mar 18, 2026
Publication

Compositions And Methods For Diagnosis, Treatment Of And Prevention Of Kidney Disease

EP4453235A2 · XORTX Therapeutics Inc. · Mar 18, 2026
Publication

Pyrimidine Heterocyclic Compound, Preparation Method Therefor And Use Thereof In Medicine

EP4455132A1 · Insilico Medicine IP Limited · Mar 18, 2026
Publication

Substituted Fused Heterocyclic Compound, And Preparation Method Therefor And Use Thereof

EP4455144A1 · Shanghai Annova Biotechnology Co., Ltd. · Mar 18, 2026
Publication

O Glycoprotein 2 Acetamido 2 Deoxy 3 D Glycopyranosidase Inhibitors

EP4186899A1 · Biogen MA Inc. · Mar 18, 2026
Publication

8 (Azetidin 1 Yl) [1,2,4]Triazolo[1,5 A] Pyridinyl Compounds, Compositions And Methods Of Use Thereof

EP4198036A1 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

Thyroid Hormone Receptor ¿ Agonist Compounds, Preparation Method Therefor, And Use Thereof

EP2024138317A1 · Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences · Mar 18, 2026
Publication

Tau Tubulin Kinase (Ttbk) Inhibitor Compounds

EP4368182A1 · Consejo Superior De Investigaciones Científicas - CSIC · Mar 18, 2026
Publication

Bcat2 Inhibitors

EP4430036A2 · Agios Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Mk2 Degraders And Uses Thereof

EP4363416A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Cannabichromene Derivatives And Methods For Making And Using The Same

EP4363411A1 · University of Mississippi · Mar 18, 2026
Publication

Smarca Degraders And Uses Thereof

EP4363425A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Fgfr4 Inhibitor Acid Salt, Preparation Method Therefor, And Use Thereof

EP4450499A1 · Abbisko Therapeutics Co., Ltd. · Mar 18, 2026
Publication

Inhibitors Of Menin Mll Interaction

EP4444300A2 · Bala Therapeutics, Inc. · Mar 18, 2026
Publication

Compositions And Methods For Treating Cancer

EP4444716A1 · Kainos Medicine, Inc. · Mar 18, 2026
Publication

Bifunctional Chimeric Molecules For Labeling Of Kinases With Target Binding Moieties And Methods Of Use Thereof

EP4433458A2 · The Broad Institute, Inc. · Mar 18, 2026
Publication

Ras Inhibitors, Compositions And Methods Of Use Thereof

EP4416131A1 · Genetolead Inc. · Mar 18, 2026
Publication

Octahydro Fused Azadecalin Glucocorticoid Receptor Modulators

EP4219494A1 · Corcept Therapeutics Incorporated · Mar 18, 2026
Publication

Antagonists Of Cav 2.3

EP4436664A1 · Lario Therapeutics Limited · Mar 18, 2026
Publication

Novel Ionizable Lipids And Lipid Nanoparticles And Methods Of Using The Same

EP4433450A1 · Sail Biomedicines, Inc. · Mar 18, 2026
Publication

Orally Bioavailable Nucleoside Analogs

EP4355755A1 · Venatorx Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Deuterated (Trifluoromethyl)pyrimidine 2 Amine Compounds As Potentiators Of The Hmrgx1 Receptor

EP4429764A1 · ELI LILLY AND COMPANY · Mar 18, 2026
Publication

Development Of A New Family Of Nanocarriers Derived From Natural Tetrameric Acid Lipids

EP4433449A1 · Université de Rennes · Mar 18, 2026
Publication

Safe Administration Of Mmp 12 Inhibitor

EP4351566A1 · Foresee Pharmaceuticals USA, Inc. · Mar 18, 2026
Publication

Methods For The Production Of Tryptophans, Tryptamines, Intermediates, Side Products And Derivatives

EP4426676A2 · MIAMI UNIVERSITY · Mar 18, 2026
Publication

Lpa Receptor Antagonists And Uses Thereof

EP4444707A1 · GILEAD SCIENCES, INC. · Mar 18, 2026
Publication

Process Of Preparation Of Indoxacarb And Its Intermediates

EP4460499A1 · ADAMA MAKHTESHIM LTD. · Mar 18, 2026
Publication

Cyclopentathiophene Carboxamide Derivatives As Platelet Activating Factor Receptor Antagonists

EP4452985A1 · BOEHRINGER INGELHEIM INTERNATIONAL GMBH · Mar 18, 2026
Publication

Substituted 2 (2,6 Dioxopiperidin 3 Yl) 5 (1 Piperidin 4 Yl)isoindoline 1,3 Dione Derivatives And Uses Thereof

EP4329744A1 · Neomorph, Inc. · Mar 18, 2026
Publication

Bifunctional Molecules For Selective Modification Of Target Substrates

EP4320126A2 · The Broad Institute, Inc. · Mar 18, 2026
Publication

Synthetic Rocaglates With Broad Spectrum Antiviral Activities And Uses Thereof

EP4322940A1 · Memorial Sloan-Kettering Cancer Center · Mar 18, 2026
Publication

Pyrazolo[3,4 B]Pyridine Compounds For The Treatment Of Autoimmune Disease

EP4405051A1 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

Metal Complex, Semiconductor Layer Comprising A Metal Complex And Organic Electronic Device

EP4406385A1 · Novaled GmbH · Mar 18, 2026
Publication

Use Of Sos1 Inhibitors With Ras Inhibitors To Treat Cancers

EP4319745A1 · Revolution Medicines, Inc. · Mar 18, 2026
Publication

Pyrimidine Derivative Having Protein Kinase Inhibitory Activity, And Therapeutic Pharmaceutical Composition Comprising Same

EP4286376A1 · Therapex Co., Ltd. · Mar 18, 2026
Publication

Heteroaryl Derivatives As Pd1/Pd L1 Inhibitors For The Treatment Of Hbv And Cancer

EP4313968A2 · Arbutus Biopharma Corporation · Mar 18, 2026
Publication

Compounds And Methods For Liquid Phase Synthesis

EP4392404A1 · Eli Lilly and Company · Mar 18, 2026
Publication

Compounds For Regulating Trained Immunity, And Their Methods Of Use

EP4308105A1 · Trained Therapeutix Discovery, Inc. · Mar 18, 2026
Publication

Method For Using Reduction To Prepare (S) Nicotine

EP4349995A1 · Porton Pharma Solutions Ltd. · Mar 18, 2026
Publication

Tyk2 Degraders And Uses Thereof

EP4423086A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Cdk2 Degraders And Uses Thereof

EP4334307A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Irak4 Degraders And Uses Thereof

EP4291197A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Irak4 Degraders And Uses Thereof

EP4291187A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Antibody Drug Conjugate, Preparation Method Therefor And Application Thereof

EP4331616A1 · Tsinghua University · Mar 18, 2026
Publication

Alkyl Carboxylic Acid Compounds And Application Thereof

EP4339184A1 · Medshine Discovery Inc. · Mar 18, 2026
Publication

Artemisinin Proteasome Inhibitor Conjugates And Their Use In The Treatment Of Disease

EP4281066A2 · Cornell University · Mar 18, 2026
Publication

Radioactive Halogen Labeled Precursor Compound

EP4282857A1 · Institute of Science Tokyo · Mar 18, 2026
Publication

Pyridine Sulfonamide Derivatives As Sigma Ligands

EP4330248A1 · Acondicionamiento Tarrasense · Mar 18, 2026
Publication

Small Molecule Antagonists For The Relaxin 3/Rxfp3 System

EP4304630A1 · Research Triangle Institute · Mar 18, 2026
Publication

Arylsulfoxamides As Orexin Receptor Agonists

EP4301728A1 · Research Triangle Institute · Mar 18, 2026
Publication

Compositions And Methods For Enhancing Anti Viral Therapies

EP4301355A2 · XORTX Therapeutics Inc. · Mar 18, 2026
Publication

Heteroaryl Derivatives As Apelin Receptor Agonists

EP4298091A1 · Research Triangle Institute · Mar 18, 2026
Publication

Organic El Element Material, Organic El Element, Display Device, And Illumination Device

EP4300610A1 · Toray Industries, Inc. · Mar 18, 2026
Publication

Smarca Degraders And Uses Thereof

EP4294790A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Substituted Hydantoin Compounds, Methods For Preparation Thereof And Use Thereof In The Treatment And/Or Prevention Of A Corona Virus Disease

EP4329883A1 · Carlsson, Jens · Mar 18, 2026
Publication

Urea Derivatives For Treating Uveal Melanoma

EP4322944A1 · Centre National de la Recherche Scientifique · Mar 18, 2026
Publication

Microbiocidal Quinoline/Quinoxaline Isoquinoline Derivatives

EP4326710A1 · Syngenta Crop Protection AG · Mar 18, 2026
Publication

Spirocyclic Imidazolidinones And Imidazolidinediones For Treatment Of Light Chain Amyloidosis

EP4326721A1 · Protego Biopharma, Inc. · Mar 18, 2026
Publication

Inhibitors Of Dna Dependent Protein Kinase And Compositions And Uses Thereof

EP4323360A1 · Intellia Therapeutics, Inc. · Mar 18, 2026
Publication

New Pyrazolo[1,5 A]Pyrimidine Derivatives As Sigma Ligands

EP4323363A1 · Acondicionamiento Tarrasense · Mar 18, 2026
Publication

A Process For Preparation Of Substituted Enamine Compounds

EP4323332A1 · DSM IP Assets B.V. · Mar 18, 2026
Publication

Camptothecine Antibody Drug Conjugates And Methods Of Use Thereof

EP4277629A1 · R.P. Scherer Technologies, LLC · Mar 18, 2026
Publication

Organic Electronic Devices Comprising Bis(((Z) 3 (4 Cyano 3,5 Bis(trifluoromethyl)phenyl) 4 Oxopent 2 En 2 Yl)oxy)copper(ii) Or The Corresponding Aluminium(iii) Or Iron(iii) Complexes Or Similar Complexes

EP4355731A1 · Novaled GmbH · Mar 18, 2026
Publication

Enantiomers Of Substituted Thiazoles As Antiviral Compounds

EP4209491A1 · Innovative Molecules GmbH · Mar 18, 2026
Publication

Process For Preparing Heterocyclic Compounds For The Treatment Of Disease And Intermediate Compounds Used Therein

EP4163281A1 · Oppilan Pharma Ltd. · Mar 18, 2026
Publication

Heterocyclic Compounds As Ret Kinase Inhibitors

EP4104837A2 · Cancer Research Technology Limited · Mar 18, 2026
Publication

Pyrazolopyrimidine Compounds Useful As Ret Inhibitors

EP4105219A1 · Cancer Research Technology Limited · Mar 18, 2026
Publication

2,4 Diaminoquinazoline Derivatives And Medical Uses Thereof

EP4059924A1 · Janssen Sciences Ireland Unlimited Company · Mar 18, 2026
Publication

A Method For Synthesizing A Two Dimensional Material Consisting Of Conjugated Aromatic Structures By Trimerization

EP4269413A1 · Freie Universität Berlin · Mar 18, 2026
Publication

Rho Kinase Inhibitors

EP4116293A2 · Kadmon Corporation, LLC · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4271664A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Smarca Degraders And Uses Thereof

EP4259144A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Smarca Degraders And Uses Thereof

EP4259612A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4259128A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Tetrahydroquinazoline Derivatives As Selective Cytotoxic Agents

EP4259608A1 · Merck Sharp & Dohme LLC · Mar 18, 2026
Publication

Peptide Receptor Radionuclide Therapy

EP4255891A1 · The Regents of University of California · Mar 18, 2026
Publication

Molecules Having Pesticidal Utility And Intermediates And Processes Related Thereto

EP4313939A1 · Corteva Agriscience LLC · Mar 18, 2026
Publication

Heterocyclic Derivatives As Janus Kinase Inhibitors

EP4308122A1 · Chiesi Farmaceutici S.p.A. · Mar 18, 2026
Publication

Organic Electroluminescent Materials And Devices

EP4092036A1 · Universal Display Corporation · Mar 18, 2026
Publication

1,4 Disubstituted Pyridazine Derivatives And Their Use For Treating Smn Deficiency Related Conditions

EP4105208A1 · Novartis AG · Mar 18, 2026
Publication

Biaryl Compositions And Methods For Modulating A Kinase Cascade

EP4063360A1 · Athenex, Inc. · Mar 18, 2026
Publication

Tyk2 Inhibitors And Uses Thereof

EP4019518A1 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Compounds For Prevention Or Treatment Of Neurodegenerative Disorders

EP4200299A1 · 1st Biotherapeutics, Inc. · Mar 18, 2026
Publication

Pyrimidinone Compounds And Uses Thereof

EP4200281A1 · Hutchison Medipharma Limited · Mar 18, 2026
Publication

Proteasome Enhancers And Uses Thereof

EP4196121A1 · Board Of Trustees Of Michigan State University · Mar 18, 2026
Publication

Donepezil Ether Palmitate Or Pharmaceutically Acceptable Salt Thereof

EP4198021A1 · Chong Kun Dang Pharmaceutical Corp. · Mar 18, 2026
Publication

Salt And Crystal Form Of Pyrimidine Compound, And Preparation Methods Therefor

EP4190781A1 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Irak Inhibitors And Uses Thereof

EP4142717A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Thiohydroxypyridine Chelates

EP4232029A1 · Lumiphore, Inc. · Mar 18, 2026
Publication

Double Degraders And Uses Thereof

EP4232059A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

N [3 (Methylthio) Imidazo[1,2 A]Pyridin 2 Yl] Benzamide Derivatives And Similar Compounds As Arthropod Controlling Agents

EP4223756A1 · SUMITOMO CHEMICAL COMPANY, LIMITED · Mar 18, 2026
Publication

Novel Biaryl Derivative Useful As Diacylglycerol Acyltransferase 2 Inhibitor, And Use Thereof

EP4206193A1 · LG Chem, Ltd. · Mar 18, 2026
Publication

Water Soluble Formulations Containing Cannabinoids

EP4135770A1 · National Research Council of Canada · Mar 18, 2026
Publication

Octahydropyrazinodiazanaphthyridine Dione Compounds

EP4129997A1 · Medshine Discovery Inc. · Mar 18, 2026
Publication

Amorphous Solid Dispersions

EP4262756A1 · UCB Biopharma SRL · Mar 18, 2026
Publication

New Catalyst For Producing Polyurethanes

EP4267642A1 · BASF SE · Mar 18, 2026
Publication

New Aryl Pyrido Pyrimidin One Derivatives

EP4263541A1 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

Pharmaceutical Compositions Of 6 (2 (2 H Tetrazol 5 Yl)ethyl) 6 Fluorodecahydroisoquinoline 3 Carboxylic Acid And Ester Derivatives Thereof

EP4175635A1 · Sea Pharmaceuticals LLC · Mar 18, 2026
Publication

Organic Electroluminescent Element

EP4174062A1 · NIPPON STEEL Chemical & Material Co., Ltd. · Mar 18, 2026
Publication

Compositions And Methods For Modulating Hair Growth

EP4172159A1 · The Regents of the University of California · Mar 18, 2026
Publication

Imiquimod Cocrystals

EP4167975A1 · CELISTA PHARMACEUTICALS LLC · Mar 18, 2026
Publication

High Temperature Self Crosslinking Based Flame Retardant Droplet Resistant Copolyester, And Preparation Method Therefor And Application Thereof

EP4169967A1 · Sichuan University · Mar 18, 2026
Publication

Indolo[3.2.1 Jk]Carbazole 6 Carbonitrile Derivatives As Blue Emitters In Oleds

EP4263544A1 · UDC Ireland Limited · Mar 18, 2026
Publication

Crystalline Forms Of Irak Degraders

EP4161575A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Deuterated Irak Degraders And Uses Thereof

EP4161521A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Piperidine 2,6 Diones As Small Molecule Degraders Of Helios And Methods Of Use

EP4153175A1 · Dana-Farber Cancer Institute, Inc. · Mar 18, 2026
Publication

Mdm2 Degraders And Uses Thereof

EP4121043A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Ferroptosis Inhibitors Diarylamine Para Acetamides

EP4114375A1 · Sironax Ltd. · Mar 18, 2026
Publication

Nitrogenous Compounds For Organic Electroluminescent Devices

EP4263543A1 · UDC Ireland Limited · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4100004A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Tetrahydropyrazolo Pyrazinyl Dihydroimidazolone Or Tetrahydropyrazolo Pyridinyl Dihydroimidazolone Compounds And Methods Of Using Same

EP4182020A1 · Eccogene Inc. · Mar 18, 2026
Publication

Compounds And Uses Thereof

EP4096668A1 · Foghorn Therapeutics Inc. · Mar 18, 2026
Publication

Indazole Derivatives As Cannabanoid Receptor Partial Agonists

EP4097088A1 · Research Triangle Institute · Mar 18, 2026
Publication

Tableted Alpha Alumina Catalyst Support

EP4171801A1 · BASF SE · Mar 18, 2026
Publication

Cycloalkyl Pyrimidines As Ferroportin Inhibitors

EP4143178A1 · Global Blood Therapeutics, Inc. · Mar 18, 2026
Publication

Azalactam Compounds As Hpk1 Inhibitors

EP4143186A1 · Pfizer Inc. · Mar 18, 2026
Publication

New Triazinoindole Compounds

EP4143192A1 · JANSSEN Pharmaceutica NV · Mar 18, 2026
Publication

Bicyclic Kinase Inhibitors And Uses Thereof

EP4143191A2 · iOmx Therapeutics AG · Mar 18, 2026
Publication

N (Heterocyclyl And Heterocyclylalkyl) 3 Benzylpyridin 2 Amine Derivatives As Sstr4 Agonists

EP4126849A1 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Regioselective Oxidation Of Heterocyclic Alpha Amino Amides

EP4139283A2 · PharmaZell GmbH · Mar 18, 2026
Publication

Substituted Triazinones As Thyroid Hormone Receptor Agonists

EP4090652A1 · Eccogene Inc. · Mar 18, 2026
Publication

P38 Alpha Mitogen Activated Protein Kinase Inhibitors

EP4153303A1 · GEN1E Lifesciences Inc. · Mar 18, 2026
Publication

An Organic Electroluminescent Device Comprising A Substrate, An Anode Layer And A Cathode Layer, At Least One Light Emitting Layer, And At Least One Semiconductor Layer That Comprises At Least One Metal Compound Of A Metal And At Least One Ligand

EP4105201A1 · Novaled GmbH · Mar 18, 2026
Publication

Macrocyclic Pad4 Inhibitors Useful As Immunosuppressant

EP4100405A1 · Bristol-Myers Squibb Company · Mar 18, 2026
Publication

Method For Producing (Meth)acrylic Acid Amide Compound

EP3909942A1 · Ricoh Company, Ltd. · Mar 18, 2026
Publication

Processes For Preparing Oligonucleotides

EP4182315A1 · Changzhou Syntheall Pharmaceuticals Co., Ltd. · Mar 18, 2026
Publication

Enantioselective Chemo Enzymatic Synthesis Of Optically Active Amino Amide Compounds

EP4139468A1 · PharmaZell GmbH · Mar 18, 2026
Publication

A Ce(iv) Metal Complex, An Organic Electronic Device Comprising An Anode Layer, A Cathode Layer And A Charge Generation Layer, Wherein The Charge Generation Layer Comprises A P Type Charge Generation Layer That Comprises The Ce(iv) Metal Complex And A N Type Charge Generation Layer

EP4199131A1 · Novaled GmbH · Mar 18, 2026
Publication

Flavagline Derivatives

EP3998257A1 · PIERRE FABRE MEDICAMENT · Mar 18, 2026
Publication

Organic Electroluminescent Compound And Organic Electroluminescent Device Including The Same

EP4011872A1 · SFC Co., Ltd. · Mar 18, 2026
Publication

1,2,4 Oxadiazole And Thiadiazole Compounds As Immunomodulators

EP4023645A1 · Aurigene Oncology Limited · Mar 18, 2026
Publication

Compounds And Compositions As Inhibitors Of Endosomal Toll Like Receptors

EP4059934A1 · Novartis AG · Mar 18, 2026
Publication

Novel Lactam Compound Or Salt Thereof, Complex, And Fertilizer And Plant Growth Regulator Containing Said Compound Or Salt And Complex

EP4129995A1 · Aichi Steel Corporation · Mar 18, 2026
Publication

Polyvalent Derivatives Of Emoxypine

EP3920921A1 · Riesner Verwaltungs GmbH · Mar 18, 2026
Publication

3 Amino 4 H Benzo[E][1,2,4]Thiadiazine 1,1 Dioxide Derivatives As Inhibitors Of Mrgx2

EP3962901A1 · Solent Therapeutics, LLC · Mar 18, 2026
Publication

Inhibitors Of Human Immunodeficiency Virus Replication

EP3962603A1 · ViiV Healthcare UK (No.5) Limited · Mar 18, 2026
Publication

Compositions Comprising Deuterated Heterocyclic Gamma Carboline And Their Use In The Treatment Or Prophylaxis Of A Central Nervous System Disorder

EP3888656A1 · Intra-Cellular Therapies, Inc. · Mar 18, 2026
Publication

Tyk2 Pseudokinase Ligands

EP4054581A1 · Ventyx Biosciences, Inc. · Mar 18, 2026
Publication

Charged Ion Channel Blockers And Methods For Use

EP4054559A1 · Nocion Therapeutics, Inc. · Mar 18, 2026
Publication

Biomarker Based Treatment Of Focal Segmental Glomerulosclerosis And Diabetic Kidney Disease

EP4037680A1 · GFB (ABC), LLC · Mar 18, 2026
Publication

Phosphodiesterase Inhibitors And Use

EP4034094A1 · Zenshine Pharmaceuticals (Nanjing) Group Co., Ltd. · Mar 18, 2026
Publication

Agricultural And Horticultural Pesticide Having As Active Component Condensed Heterocyclic Compound Having Substituted Cyclopropane Oxadiazole Group Or Salt Thereof; Ectoparasite Or Endoparasite Control Agent For Animals; And Use Method Thereof

EP4029571A1 · Nihon Nohyaku Co., Ltd. · Mar 18, 2026
Publication

Anti Fibrotic Compounds And Use Thereof

EP4025559A1 · Hadasit Medical Research Services and Development Ltd. · Mar 18, 2026
Publication

Pharmaceutically Active Pyrazolo Pyridone Modulators Of Dcn1/2 Mediated Cullin Neddylation

EP3986893A1 · University Of Kentucky Research Foundation · Mar 18, 2026
Publication

Method For Preparing Indole Or Indazole Compound

EP3971183A1 · LG Chem, Ltd. · Mar 18, 2026
Publication

Smarca Degraders And Uses Thereof

EP4081308A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4076524A2 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4076536A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4076520A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4072591A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Benzothiophene Compound, Preparation Method Therefor And Use Thereof

EP3964504A1 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Bromodomain Inhibitors

EP4051383A1 · Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen · Mar 18, 2026
Publication

A Class Of Bifunctional Chimeric Heterocyclic Compounds For Targeted Degradation Of Androgen Receptors And Use Thereof

EP3957633A1 · Hinova Pharmaceuticals Inc. · Mar 18, 2026
Publication

Stat Degraders And Uses Thereof

EP3946360A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Nonpeptide Somatostatin Type 5 Receptor Agonists And Uses Thereof

EP4013748A1 · Crinetics Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Heterocyclic Compound

EP4005637A1 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Benzenesulfonamide Derivatives And Uses Thereof

EP4017843A1 · 2692372 Ontario, Inc. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP3989966A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Method For Preparing Aromatic Amino Acid Derivative

EP3939962A1 · CHUGAI SEIYAKU KABUSHIKI KAISHA · Mar 18, 2026
Publication

Substituted 2 Heteroaryl Aminobenzenes, Their Salts And Use Of Said Compounds As Herbicidal Agents

EP3947350A1 · Bayer Aktiengesellschaft · Mar 18, 2026
Publication

Pyrazolylbenzene 1,3 Diols For Diseases Associated With G Protein Coupled Receptor 18 And In Combination With Transient Receptor Potential Vanilloid 1

EP3901142A1 · Consejo Superior de Investigaciones Científicas (CSIC) · Mar 18, 2026
Publication

Substituted Indoles And Methods Of Use Thereof

EP3837240A1 · Epizyme, Inc. · Mar 18, 2026
Publication

Kif18 A Inhibitors

EP3897852A1 · Amgen Inc. · Mar 18, 2026
Publication

Novel P62 Ligand Compound, And Composition For Preventing, Alleviating, Or Treating Proteinopathies Comprising Same

EP3828163A1 · Autotac Inc. · Mar 18, 2026
Publication

Protein Degraders And Uses Thereof

EP3817822A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Heterocyclic Compound, Organic Light Emitting Diode Comprising Same, Composition For Organic Layer Of Organic Light Emitting Diode, And Method For Manufacturing Organic Light Emitting Diode

EP3812381A1 · LT Materials Co., Ltd. · Mar 18, 2026
Publication

Prodrugs Of Hiv Reverse Transcriptase Inhibitors

EP3785714A1 · Merck Sharp & Dohme LLC · Mar 18, 2026
Publication

Compound And An Organic Semiconducting Layer, An Organic Electronic Device And A Display Device Comprising The Same

EP3898606A1 · Novaled GmbH · Mar 18, 2026
Publication

Camptothecin Peptide Conjugates

EP3773736A1 · Seagen Inc. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP3886904A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Compounds, Compositions, And Methods For Modulating Ferroptosis And Treating Excitotoxic Disorders

EP3887351A1 · The Trustees of Columbia University in the City of New York · Mar 18, 2026
Publication

Method Of Manufacturing Gadobutrol

EP3819294A1 · ST Pharm Co., Ltd. · Mar 18, 2026
Publication

Combinations Of Relacorilant And A Radiolabelled Somatostatin Analogue For Use In Localising Neuroendocrine Tumours

EP3897629A1 · Corcept Therapeutics Incorporated · Mar 18, 2026
Publication

Protein Degraders And Uses Thereof

EP3684365A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Hepatitis B Antiviral Agents

EP3675637A1 · Enanta Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Novel Method For Producing Antibody Drug Conjugate

EP3677568A1 · Daiichi Sankyo Company, Limited · Mar 18, 2026
Publication

Biomimetic Nanomaterials And Uses Thereof

EP3661563A1 · The Ohio State Innovation Foundation · Mar 18, 2026
Publication

Organic Electronic Device Comprising A Compound Of Formula (1), Display Device Comprising The Organic Electronic Device

EP3989301A1 · Novaled GmbH · Mar 18, 2026
Publication

Water Monitoring Device With Replaceable Reagent Cartridge

EP3931181A1 · Sutro Connect, Inc. · Mar 18, 2026
Publication

Agonists Of Peroxisome Proliferator Activated Receptor Alpha And Methods Of Use

EP3765450A1 · The Board of Regents of the University of Oklahoma · Mar 18, 2026
Publication

N Cyano 7 Azanorbornane Derivatives And Uses Thereof

EP3837262A1 · Amgen Inc. · Mar 18, 2026
Publication

Heterocyclene Derivates As Pesticides

EP3692045A1 · Bayer Aktiengesellschaft · Mar 18, 2026
Publication

Heterocyclic Compound

EP3661931A1 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Dihydrobenzimidazolones

EP3679027A1 · C4 Therapeutics, Inc. · Mar 18, 2026
Publication

Salts And Solid State Forms Of Plinabulin

EP3661927A1 · Assia Chemical Industries Ltd. · Mar 18, 2026
Publication

Nitrogenated Heterocyclic Amide Compound, And Use Thereof For Medical Purposes

EP3747888A1 · Japan Tobacco Inc. · Mar 18, 2026
Publication

Compound And Organic Semiconducting Layer, Organic Electronic Device, Display Device And Lighting Device Comprising The Same

EP3824500A1 · Novaled GmbH · Mar 18, 2026
Publication

Protein Degraders And Uses Thereof

EP3737666A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Crbn Ligands And Uses Thereof

EP3737675A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Oxadiazoles As Agonists Of The Muscarinic M1 And/Or M4 Receptor

EP3810607A1 · Nxera Pharma UK Limited · Mar 18, 2026
Publication

Compounds For The Treatment Of Kinase Dependent Disorders

EP3743417A1 · Exelixis, Inc. · Mar 18, 2026
Publication

Modulators Of The Integrated Stress Pathway

EP3704115A1 · Calico Life Sciences LLC · Mar 18, 2026
Publication

Pharmaceutical Forms Of Diazabicyclooctane Derivatives And Manufacturing Method Thereof

EP3687993A1 · Meiji Seika Pharma Co., Ltd. · Mar 18, 2026
Publication

Small Molecule Dcn1 Inhibitors And Therapeutic Methods Using The Same

EP3601245A1 · The Regents of The University of Michigan · Mar 18, 2026
Publication

Compounds Comprising Triazine Group, Fluorene Group And Aryl Group And Their Use In Organic Electronic Devices

EP3483153A1 · Novaled GmbH · Mar 18, 2026
Publication

Compounds And Uses Thereof

EP3529245A1 · Janssen Pharmaceutica NV · Mar 18, 2026
Publication

Inhibitors Of Cytochrome P450 Family 7 Subfamily B Member 1 (Cyp7 B1) For Use In Treating Diseases

EP3558304A2 · Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) · Mar 18, 2026
Publication

Compositions Comprising Low Impact Ampakines For Treating Attention Deficit Disorders

EP3436021A1 · RespireRx Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Commercially Viable Synthesis Of Cantharidin And Bioactive Cantharidin Derivatives

EP3233865A2 · Verrica Pharmaceuticals Inc. · Mar 18, 2026
Publication

Methods And Compositions Particularly For Treatment Of Attention Deficit Disorder

EP3212172A1 · Purdue Pharma · Mar 18, 2026
Publication

7 A Heterocycle Substituted 6, 6 Difluoro Bicyclic Himbacine Derivatives

EP3035930A1 · Merck Sharp & Dohme LLC · Mar 18, 2026
Publication

Crystalline Form 4 Of 4 (5 (4,7 Dimethylbenzofuran 2 Yl) 1,2,4 Oxadiazol 3 Yl)benzoic Acid, A Processes For Its Preparation And Uses Thereof

EP3475274A1 · King's College London · Mar 18, 2026
Publication

Crystalline Forms Of N [2 (3 Hydroxy 3 Methylbutyl) 6 (2 Hydroxypropan 2 Yl) 2 H Indazol 5 Yl] 6 (Trifluoromethyl)pyridine 2 Carboxamide

EP3448847A1 · Bayer Pharma Aktiengesellschaft · Mar 18, 2026
Publication

Solid State Forms Of Venetoclax And Processes For Preparation Of Venetoclax

EP3426655A1 · Assia Chemical Industries Ltd. · Mar 18, 2026
Publication

Method For Modifying The Surface Composition Of Alpha Alumina

EP2620212A2 · Dow Global Technologies LLC · Mar 18, 2026